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INTRODUCTION 
The work presented in this thesis was undertaken as part of a con­
tinuing effort to understand in detail the mechanism of catalysis by 
the enzyme aspartate aminotransferase. This enzyme is especially well 
suited for such a study because it contains the cofactor pyridoxal 
5'-phosphate (PLP) at each active site. The cofactor forms a covalent 
bond with the substrate in the active site and is intimately involved 
in catalysis. Moreover the cofactor acts as a "reporter group," reflect­
ing changes at the active site through changes in its absorption, 
circular dichroism, and fluorescence spectra. 
Pyridoxal phosphate and many of its analogs are quite capable of 
catalyzing transamination reactions in solution without the apoenzyme. 
In fact the general theory of pyridoxal-dependent enzymatic reactions 
as proposed by Metzler ejt (1954) was based on the study of such 
model reactions and agreed well with the theory of Braunstein and 
Shemyakin (1953), which was based on the reactions of known pyridoxal-
dependent enzymes. From model studies the basic involvement of the 
cofactor is now well understood. 
However, there are fundamental differences between catalysis in 
model systems and in aspartate aminotransferase. Model systems are 
strongly stimulated by divalent and tri valent metal ions while the 
enzyme uses no metal. Pyridoxal in model systems catalyzes a variety 
of reactions at once, but the enzyme catalyzes the transamination 
reaction only, and at rates several orders of magnitude greater than 
those in nonenzymatic systems. Furthermore, a wide variety of amino 
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acids and pyridoxal analogs are active in nonenzymatic transamination 
reactions while the enzyme is highly specific for its substrates and for 
pyridoxal phosphate. These differences must be due to the protein. 
The protein imposes constraints on the reaction. The active site 
has a geometry such that only certain coenzymes and substrates are able 
to bind. Specific groups on the protein actively participate in catal­
ysis, directing the reaction for transamination by accelerating only 
the rate of transamination and by inhibiting side reactions. 
The goal of this research is to obtain information about the struc­
ture of the protein moiety of aspartate aminotransferase and about its 
interaction with the coenzyme pyridoxal phosphate. Detailed struc­
tural information is most easily obtained through X-ray crystallography, 
and for this reason many researchers have sought to crystallize some 
form of aspartate aminotransferase. Recently three groups have succeeded 
in crystallizing the enzyme from different sources (chicken heart 
cytosol, chicken heart mitochondria, and pig heart cytosol) and have 
begun the crystallographic structure determination. Of the three, the 
pig heart cytosolic enzyme is by far the best characterized. 
Again, aspartate aminotransferase offers special advantages over 
most enzymes. The active site is clearly marked by the presence of 
pyridoxal phosphate. Furthermore, the enzyme forms crystalline com­
plexes with the substrates J^-glutamate and ^-aspartate and with the 
pseudo-substrates a-methylaspartate and 3-hydroxyaspartate, which form 
stable transamination intermediates with the enzyme in solution. The 
polarized light absorption spectra of these crystalline complexes, 
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which are thought to be true enzyme-substrate complexes, are being 
studied. The spectra indicate that transamination can occur in the 
crystals of both the pig heart cytosolic enzyme (Metzler et , 1978) 
and the chicken heart mitochondrial enzyme (Eichele e;t , 1978). 
Crystals of the a-methylaspartate and the 3-hydroxyaspartate complexes 
with the pig heart enzyme are known to be isomorphous with those of 
the native enzyme. It should soon be possible to obtain difference 
maps which show any changes in the active site which occur during cat­
alysis. It is hoped that these crystalline transamination intermedi­
ates will be an invaluable aid in constructing a detailed model of 
the events that occur at the active site of aspartate aminotransferase 
during catalysis. 
Before detailed difference maps can be calculated, it is nec­
essary to obtain a good high-resolution electron density map of the 
native enzyme. The first part of this dissertation concerns attempts 
to prepare crystalline heavy atom derivatives of the enzyme. Taking 
advantage of the varying reactivities of the five sulfhydryl groups 
of aspartate aminotransferase, I modified samples of the enzyme at 
specific sites with mercury-containing reagents, and then tried to 
crystallize the modified proteins. A variety of sulfhydryl blocking 
groups and mercury reagents were used in order to find a combination 
that would give crystals that were isomorphous with crystals of the 
native enzyme. 
Analogs of pyridoxal 5'-phosphate have been used extensively 
to probe the active site of aspartate aminotransferase and to map 
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some of the hydrophobic and electronic interactions of the coenzyme 
with the protein. Two analogs (Figure 1), pyridoxal 5'-sulfate (PLS) 
and a 5'-trans-carboxyethenyl analog of PLP, provide the basis of the 
second part of this dissertation. From previous studies, it appears 
that PLS initially binds to the active site of the apoenzyme as a 
Schiff base, like pyridoxal phosphate, but then undergoes further 
reactions to become covalently bound to the protein. The carboxy-
ethenyl analog appears to react similarly. It was proposed that a 
nucleophilic group of the protein, possibly the same group in both 
cases, added to the Schiff base in the reactions and that the coenzyme 
analogs thus may act as crosslinking reagents for two residues at the 
active site of aspartate aminotransferase. Isolation of modified 
peptides from these reactions and identification of the amino acid 
residues involved in the reactions would give information about the 
geometry of the active site and about the nature of the reactions of 
these coenzyme analogs with the protein. In addition* it may be possible 
to locate another amino acid residue at the active site, in close prox­
imity to the active site lysine, and this would help in tracing the 
polypeptide chain in the X-ray structure determination. 
Analogs of pyridoxal phosphate, including PLS and the carboxy-
ethenyl analog, have in the past been assumed to bind to the active site 
of aspartate aminotransferase on the basis of their ability to inhibit 
the binding of pyridoxal phosphate. It is important that in at least 
one case a peptide modified by one of these analogs be isolated and 
identified as the peptide that contains the active site lysine in order 
Pv 0 
Figure 1 Structures of coenzymes used in this study. I. pyridoxal 
5'-phosphate. II. pyridoxal 5'-sulfate. III. 5'-trans-
carboxyethenyl analog. 
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to demonstrate that this assumption is valid. This is another goal of 
this research. 
For this purpose I digested apoAAT modified by PLS or the carboxy-
ethenyl analog with pepsin to obtain small peptides that contained the 
more stable low pH forms of the chromophoric products. At low pH, the 
PLS product has a brilliant blue-white fluorescence and a characteristic 
absorption spectrum, so that the product could easily be detected and 
measured quantitatively throughout the purification procedure. The 
peptides were separated by gel chromatography and thin-layer electro­
phoresis. The peptides that contained the PLS product were used to 
identify the amino acids involved in the reaction of PLS and apo-
aminotransferase and to study the chemistry of the reaction. 
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LITERATURE REVIEW 
Aspartate Aminotransferase 
Aspartate aminotransferase (AAT) from pig heart cytosol was 
the first vitamin B^-dependent enzyme to be obtained in virtually 
pure state (Jenkins e;t , 1959), and has become the most studied 
and therefore the most thoroughly characterized enzyme of this class. 
The properties of AAT have been the subject of several reviews 
(Ivanov and Karpeisky, 1969; Braunstein, 1970; Turano et , 1970; 
Severin and Gulyaev, 1976) and are best summarized by Braunstein (1973), 
AAT is an apparently symmetric dimer with a mass of 93,147 daltons. 
The active sites function independently (Schlegel and Christen, 1974, 
1978; Boettcher and Martinez-Carrion, 1975a, 1976; Schlegel et al., 
1977). However, there are strong interactions between subunits so that 
the binding of PLP to one subunit of a dimer of apoenzyme elicits a 
conformational change in the other subunit (Schlegel and Christen, 1974; 
Arrio-Dupont and Cournil, 1975). 
There is disagreement as to whether the protomers dissociate on 
dilution. Cournil and coworkers (1975) reported a dissociation 
constant of 1.8 x 10"^ M while Melander (1975) estimated to 
be 10-fold lower. On the other hand Feliss and Martinez-Carrion 
(1970) found no evidence for dissociation of the subunits on 
dilution to 10"^^ M. The subunits can be dissociated by denaturation 
(Feliss and Martinez-Carrion, 1970) or by succinylation of the protein 
(Polyanovsky, 1965). 
Each subunit consists of a single polypeptide of 412 residues, 
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whose sequence has been determined independently by two groups 
(Ovchinnikov e^ £l. » 1973; Doonan et , 1975). One molecule of 
the cofactor pyridoxal 5'-phosphate is bound as a Schiff base to 
lysine-258 of each subunit (Fischer et , 1962; Hughes et al., 
1962). The bound coenzyme exists in several spectrophotometrically 
distinguishable forms. The enzymatically active form has an absorption 
maximum at 363 nm (27.4 kK). This form is related to another form 
absorbing at 430 nm (23.3 kK) by a single pK^ that varies between 
5.4 and 6.3, depending on the identity and concentration of the buffer 
anion (Bergami e^ , 1968). These two forms are related through 
the addition of a proton to the nitrogen atom of the Schiff base 
(Jenkins el^ al_., 1959; Cheng e;t aj_., 1971). In addition, there is an 
inactive form of the coenzyme with a pH-independent absorption max­
imum at 340 nm (29.4 kK). The nature of the enzyme-coenzyme bond 
in this form is not understood (Martinez-Carrion et 1967b). 
Starch gel electrophoresis of AAT as it was originally isolated 
gives at least three distinct bands (Martinez-Carrion et aj_., 1967b; 
Banks e^ al_., 1968). The three forms of the enzyme present in the 
major bands are known as the a, 3, and y subforms, in the order of 
their increasing anodic mobility on starch gel electrophoresis. The 
a subform contains two molecules of PLP per dimer, both bound in the 
active mode with a pH-dependent absorption maximum at 430 or 363 nm, 
as described above. The ^ form is the enzymatically most active 
subform. The y subform is the least active with its coenzyme bound 
predominately in the inactive mode, absorbing at 340 nm. The 3 
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subform has an intermediate activity and contains approximately 
one-half actively bound and one-half inactively bound PLP. Each 
dimer of the g subform has one active and one inactive monomer 
(Martinez-Carrion et a^., 1967b; Evans and Holbrook, 1974). Upon 
aging, the purified a and 3 subforms lose activity slowly as the co­
enzyme becomes bound in the inactive mode. However, the electro-
phoretic mobilities do not change (Martinez-Carrion e^ , 1957b). 
Inactive subunits can be partially reactivated by denaturation and 
renaturation. It has been proposed that denaturation may break the 
bonds responsible for the inactive mode of PLP binding. An alter­
native explanation is that the inactive mode is favored as a thermo-
dynamically more stable conformation which is formed by a slow 
transition from a less stable, but active, conformation; the latter is 
favored kinetically during renaturation (Giartosio et ^., 1973). 
The a and 3 subforms differ by a single charge in the pH range 5.6 
to 8.0, possibly due to the hydrolysis of an amide group (John and 
Jones, 1974). Consistent with this, Williams and John (1979) have 
observed the production of ammonia and generation of negative charge 
in AAT in vitro consistent with the deamination of two glutamine or 
asparagine residues per dimer. 
The mechanism of transamination by AAT is shown in the half-
reaction in Figure 2 (Braunstein, 1973). The enzyme active site 
contains the coenzyme PLP bound as a Schiff base to a lysine residue 
(I). The first step in the reaction sequence is the binding of the 
substrate amino acid to form a Michael is complex (II). The amino 
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Figure 2 Half transamination reaction, as catalyzed by aspartate 
aminotransferase. From Braunstein (1973). 
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acid substrate then presumably condenses with the internal Schiff 
base to form a transient tetrahedral adduct (III). This form is 
too short-lived to be observed spectrophotometrically. The lysine 
side chain is then released to complete the transimination from 
the enzyme-coenzyme Schiff base to the substrate-coenzyme Schiff 
base (IV). 
The third step in the reaction sequence is a prototropic 
aldimine-ketimine rearrangement. A basic group of the protein re­
moves the a-proton of the amino acid substrate to form a transient 
quinonoid structure (VI). The abstracted proton is then transferred 
to the 4'-carbon of the coenzyme in what appears to be the rate-
limiting step of the reaction (Harruff and Jenkins, 1978). Finally, 
the ketimine (VII) is hydrolyzed to a keto acid and pyridoxamine 
5'-phosphate (VIII). 
The pseudosubstrate a-methylaspartate forms a Schiff base with 
the coenzyme at the enzyme active site analogous to structure IV 
in Figure 2, but because there is no a-proton the reaction with this 
amino acid cannot proceed further. Erythro-3-hydroxyaspartate forms 
a stable quinonoid structure (VII) with the enzyme with a strong 
absorbance at 490 nm (20.3kK). This absorbance is seen only faintly 
with the substrate pair aspartate and oxaloacetate. Difluorooxalo-
acetate reacts slowly with the PMP form of the enzyme and has been 
suggested as a probe to study the aminic forms of AAT (Briley et al., 
1977a,b). 
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Reactive amino acid residues 
Several amino acid residues of AAT can be modified selectively 
with varying effects on the activity of the enzyme. Those residues 
whose modification leads to the inactivation of the enzyme are sus­
pected of being located in the active site, and in some cases have 
been assigned a role in the catalytic mechanism. The evidence of 
these chemical modification studies is indirect, and thus is not 
always reliable. Conclusions drawn from such evidence are often 
controversial. 
Lysine In the native holoenzyme the coenzyme is bound to 
the protein in a Schiff base linkage to the e-amino group of lysine 
residue 258 in the polypeptide chain (Hughes et , 1962; Ovchinnikov, 
et a].., 1973). This Schiff base not only forms a covalent link between 
the enzyme and coenzyme, but it makes the 4'-carbon of the coenzyme much 
more susceptible to nucleophilic attack than would be the free al­
dehyde (Cordes and Jencks, 1962). 
The protonated Schiff base forms one of the binding sites for 
dicarboxylic acid inhibitors of the enzyme (Martinez-Carrion et al., 
1973). Lysine-258 is alkylated by the amino acids 3-chloro-^-alanine, 
L^propargylglycine, and vinyl glycine, causing the complete inactivation 
of the enzyme (Morino and Okamato, 1973; Tanase, 1977; Gehring et al., 
1977b). The unprotonated e-amino group of this lysine residue has been 
proposed as the group that accepts a proton from the a-carbon of the 
amino acid substrate and transfers it to the 4'-carbon of the coenzyme 
during catalysis (Ayling et a^., 1968; Ivanov and Karpeisky, 1969; 
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Harruff and Jenkins, 1978). 
Histidine Both chemical modification (Turano e;t , 1966; 
Severin e;t , 1972; Kovaleva and Severin, 1972). and photoinactiva-
tion studies (Martinez-Carrion et , 1967a; Martinez-Carrion et al., 
1970; Peterson and Martinez-Carrion, 1970; Burridge and Cnurchich, 
1970; Yamasaki e^ , 1975) have been used to detect at 
least one reactive histidine residue in AAT. A histidine side chain 
was modified by the bifunctional reagent 3-bromopropionyl chloride 
which reacted first with a lysine residue, presumably lysine-258 
(Turano e^ a]_., 1966, 1970). A histidine residue may also have been 
alkylated in the reaction of the enzyme with the substrate analog 
threo-g-cycloqlutamic acid, but the product was unstable and could 
not be characterized (Kovaleva and Severin, 1972). 
The critical histidine is not involved in coenzyme binding 
(Martinez-Carrion e;t , 1970) but there is disagreement about its 
function. Because the pH-dependence of the rate of the cyclogluta-
mate reaction had an inflection point at pH 6.7, Severin et (1972) 
proposed that the imidazole of the histidine binds the a-carboxyl 
group of the substrate. Martinez-Carrion e;t aj_. (1973) proposed 
that the histidine binds a carboxyl group of the dicarboxylic acid 
inhibitors but not of substrates because the group that is involved in 
substrate binding has no pH-dependence in the range of pH 5-9. 
Photooxidized enzyme can bind substrates and form an aldimine complex. 
However it cannot catalyze a-proton exchange of an amino acid sub­
strate, and it does not show an absorption at 490 nm with hydroxy-
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aspartate due to the quinonoid intermediate. These observations 
lead to the proposal that the functional histidine residue may be the 
group that transfers the proton from the a-carbon of the amino acid 
to the 4'-carbon of the coenzyme (Ayling ejt , 1968; Peterson and 
Martinez-Carrion, 1970; Cheng and Martinez-Carrion, 1972). 
Tyrosine Christen and Riordan (1970) found that while tetra-
nitromethane (TNM) did not inactivate AAT in either the PLP or PMP 
form, in the presence of the substrate pair glutamate and a-ketoglutar-
ate,TNM inactivated the enzyme with the nitration of one tyrosine resi­
due. During the course of the reaction the enzyme was converted to the 
PMP form. Although a-ketoglutarate could bind to the modified enzyme 
and could form a Schiff base with the PMP, the coenzyme could not be 
reconverted to PLP (Bocharov e;t , 1973). In the presence of either 
substrate alone, of the substrate analog a-methylaspartate, or of the 
competitive inhibitors maleate, glutarate, or phthalate, TNM caused 
only slight inactivation. Inactivation, therefore, seemed to reflect 
a short-term change in the environment of a tyrosine residue, probably 
during or after the transition from the aldimine to the ketimine 
(Christen and Riordan, 1970). This modification was termed "syn-
catalytic" since it appeared to be synchronous with catalysis. 
Polyanovsky et_ (1972) isolated a peptide containing the nitro-
tyrosine residue and identified the reactive residue as tyrosine-40. 
Later results showed that TNM modified cysteine as well as 
tyrosine residues of the enzyme. Thus, disagreement arose about whether 
the modification of tyrosine or the modification of cysteine actually 
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caused the inactivation. Turano et (1971) found that the 
inactivation of AAT correlated better with the modification of tyrosine 
than with the modification of cysteine. On the other hand, Birchmeier 
ejt (1973b) found that the nitration of tyrosine was not as 
specific as the oxidation of cysteine since no more than one tyrosine 
per monomer was modified but only half the nitrotyrosine appeared 
in any one peptide resulting from cyanogen bromide cleavage of the 
enzyme. They concluded that the nitration of tyrosine was a secondary 
reaction facilitated by the prior oxidation of cysteine. Bocharov 
e;t (1973) selectively modified either tyrosine-40 or cysteine-390 
and found that complete inactivation occured only with modification of 
both residues. 
The bifunctional reagent difluorodinitrobenzene crosslinked the 
active site lysine and tyrosine-70 in apoAAT, establishing the presence 
of a tyrosine in the active site about 0.5 nm from lysine-258 (Turano 
e^ , 1970; Deev eib , 1978). 
Tyrosine or tryptophan Based on studies of the circular 
dichroism of the enzyme, Ivanov and Karpeisky (1960) proposed that the 
active site tyrosine is hydrogen-bonded to the pyridine N of the co­
enzyme. The circular dichroic spectra of the PMP enzyme and of the 
PLP enzyme in its high pH and low pH forms all showed a negative band 
295 to 300 nm which belonged to the enzyme but was absent in the 
spectrum of the apoenzyme. These authors maintained that only a 
tyrosine residue can account for the position and shape of this band. 
When PLP N-oxide, an analog of PLP that cannot form a hydrogen bond to 
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the ring N, was added to apoAAT, the CD spectrum again showed a 
negative band at 300 nm and a new positive band appeared at 275 nm, 
close to the absorption maximum of an unionized tyrosine. This 
was in agreement with findings that apoAAT has more tyrosines 
available to TNM than holoAAT, and that apoAAT was completely in­
activated by TNM due to the failure of nitrated apoenzyme to re-
combine with PLP (Turano e^ al^, 1971). However, because the 
circular dichroism band at 300 nm corresponds to vibronic fine struc­
ture that appeared when PLP, PMP, or coenzyme analogs were bound to 
apoAAT, Yang et aj_. (1975) ascribed this band to an alteration in 
the environment of a tryptophan residue rather than tyrosine, whose 
absorption spectrum lacks fine structure. Thus, while there probably 
is a tyrosine residue in the active site, there is uncertainty about 
its exact position and its role. 
Cysteine AAT has five cysteine and no cystine residues in 
each monomer (Ovchinnikov ^ , 1973; Doonan et al_., 1975). The 
cysteines differ greatly in their reactivities toward sulfhydryl 
reagents and in the effects of their modifications on the activity of 
the enzyme (Cournil and Arrio-Dupont, 1971; Stankewicz et ^., 1971; 
Birchmeier e^ aj^, 1973a,b). 
Cysteine-45 is the most highly reactive sulfhydryl group of the 
five and reacts with 5,5'-dithiobis(2-nitrobenzoate). (DTNB) at a rate 
of 800 M"ls"^ at pH 7.5. The rate of modification is unaffected by the 
presence of glutamate, a-ketoglutarate, or both in the reaction mixture. 
Modification of cysteine-45 with N-ethylmaleimide (NEM) or with TNM 
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causes a slight increase and decrease, respectively, in the enzymatic 
activity. Reaction of cysteine-45 with other sulfhydryl reagents 
has no effect on the activity (Zufarova ejt , 1973; Wilson et al., 
1974). Cysteine-45 can be selectively modified by NEM, DTNB, TNM • 
(Wilson et^ a^., 1974), or maleate (Polyanovsky et^ a^., 1973a). 
Cysteine-82 is also highly reactive, but reacts with DTNB about 
20 times slower than does cysteine-45. The rate of reaction is 26 
s"^ at pH 7.5, and, like that for cysteine-45 it is unaffected by the 
presence of substrates (Zufarova, ^ al_., 1973; Wilson e;t £1_., 1974). 
Fluorescence properties of mixed disulfides of N-dansylcysteine 
with cysteine-45 and cysteine-82 indicated a polar environment such as 
that of the exterior of the enzyme (Wilson ejt ^., 1974). Electron 
spin resonance studies of spin labels attached to cysteine-45 and 
cysteine-82 also indicated that the groups are located on the exterior 
of the protein 2.0-2.3 nm apart and at a distance of about 2.5 nm 
from the active site. On interaction of the spin labeled enzyme with 
substrates and with quasi substrates, the ESR spectrum of the spin label 
on cysteine-45 changed reversibly, indicating a conformational change 
in this region of the enzyme (Polyanovsky e;t , 1973b; Polyanovsky 
and Misharin, 1974). 
Two more sulfhydryl groups, cysteine-191 and cysteine-252, are un-
reactive, except under denaturing conditions (Birchmeier e;t ^., 1973a; 
Zufarova let , 1973). 
The fifth cysteine, residue 390, is only slightly reactive in the 
- 2  - 1  _ 1  
native enzyme. Its rate of reaction with DTNB is 2 x 10 M min , 
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five orders of magnitude less than that of cysteine-45 and cysteine-82. 
However^ like tyrosine-40, it becomes more reactive in the presence of 
a substrate pair and thus is also syncatalytically modifiable. In 
the presence of the substrate pair glutamate and a-ketoglutarate, this 
residue becomes twenty times more reactive and its rate of modification 
with DTNB is 4.0 x lO'^W^min"^ (Cournil and Arrio-Dupont, 1971; 
Birchmeier and Christen, 1971; Birchmeier et aJU, 1972; Torchinsky 
Ëi. il-» 1972; Birchmeier e^ , 1973a). Since cysteine-390 is less 
reactive in the presence of either substrate alone, a-methylaspartate, 
or 3-hydroxyaspartate, it is probably most reactive in the ketimine 
intermediate (Birchmeier and Christen, 1971; Birchmeier e^ aly, 1973a). 
Modification of cysteine-390 with a variety of sulfhydryl reagents 
such as NEM, DTNM, £-chloromercuribenzoate, TNM, sulfite, glutathione, 
mercaptoethanol, methylmercaptan, or 3-bromopyruvate severely impaired 
the activity of the enzyme. However, the enzyme was not completely 
inactivated and could still be quantitatively converted between the 
PLP and PMP forms by the addition of the appropriate substrate. Further­
more, when cysteine-390 was modified with cyanide, which leaves a small 
uncharged substituent, the enzyme retained 60% of its initial activity. 
It therefore seems that cysteine-390 has no essential role in catalysis 
(Birchmeier et , 1973a; Birchmeier and Christen, 1974). However, 
the residue is located very near to the active site. Difluorodinitro­
benzene crosslinked lysine-258 and cysteine-390 in apoAAT, indicating 
that the two residues are about 0.5 nm apart (Deev e;t aj_., 1978). 
The special reactivity of cysteine-390 has been utilized in a 
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variety of ways to explore the environment of this residue. From the 
fluorescence properties of a mixed disulfide of cysteine-390 with 
N-dansylcysteine, Wilson ejt aj_. (1974) concluded that the residue was 
located in a rather hydrophobic environment and near a tryptophan 
residue. Boettcher and Martinez-Carrion (1975b) modified cysteine-390 
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with ( C)-CN and recorded the nuclear magnetic resonance spectrum 
at different pH's and with the addition of substrates or substrate 
analogs. Since they found no change in the chemical shift of the 
probe, there is apparently no nearby group that ionizes under those 
conditions. Boettcher and Martinez-Carrion (1978) attached a spin 
label, 4-maleimido-2,2,6,6-tetramethylpiperidinooxyl, to cysteine-390 
and measured its effects on the nuclear magnetic resonance properties 
of various ligands bound at the active site of the enzyme. In this way 
they were able to map the distances between the spin probe and nuclei 
of the ligands. They concluded that the nitroxide ring was located 
above or below the plane of the coenzyme ring, 0.8-0.9 nm away, and 
that the a-methyl and g-methylene protons of the substrate analog 
a-methylaspartate were located in the same plane as the coenzyme ring, 
about 0.9 nm away. nuclear magnetic resonance studies of 1,1,1-
trifluoroactonylated cysteine-390 was used to detect conformational 
changes in the region of cysteine-390 when substrate was bound to the 
active site. The line width of the NMR signal decreased, indicating 
that more motion was allowed in the region of the probe (Critz and 
Martinez-Carrion, 1977a,b). 
Arqinine The arginine-specific reagents 2,3-butanedione, 
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phenylglyoxal, and 1,2-cyclohexanedione reversibly inactivated AAT 
by modifying approximately two arginine residues per subunit (Riordan 
and Scandurra, 1975; Gilbert and O'Leary, 1975). The essential 
arginines did not appear to bind the coenzyme phosphate, as had been 
expected, because the enzyme that was resolved either before or after 
phenylglyoxal modification rebound PLP with no restoration of activity 
(Riordan and Scandurra, 1975). The arginine appeared to form the 
binding site for the w-carboxyl of the substrate since incubation of 
the cyclohexanedione-modifed enzyme with aspartate, cysteine sulfinate, 
or alanine caused a decrease in the absorbance of the enzyme at 430 nm 
and an increase at 330 nm due to a slow transamination. All three sub­
strates reacted at about the same rate, although alanine is a much 
poorer substrate for the native enzyme than the others are (Gilbert and 
O'Leary, 1975). 
Threonine There is some indication of a threonine residue in 
the active site of AAT. N-Phosphopyridoxyl-J^-glutamic acid reacted at 
the active site of apoAAT to inhibit the enzyme irreversibly. Although 
this analog of the coenzyme-substrate complex is itself not an alkylating 
agent, the reaction involved transfer of the phosphate group to a 
threonine residue of the protein with the participation of nucleophilic 
group(s) of the protein. This threonine residue may be involved in the 
catalytic mechanism (Khomutov et aj_., 1969; Braunstein, 1973). 
Carboxyl groups Although blockage of 45% of the carboxyl groups 
of the enzyme greatly reduced the activity of the enzyme, Bossa et al. 
(1971) found no evidence of the presence of a carboxyl group at the 
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active center of the enzyme. 
Crystallization 
In order to understand the mechanism of catalysis by aspartate 
aminotransferase, a picture of its structure is needed. Some structur­
al information has been deduced indirectly from the modification exper­
iments discussed above, but a complete picture can be had only from 
X-ray crystallography. Therefore, many attempts have been made to 
crystallize the enzyme. Bertland and Kaplan (1968, 1970) crystallized 
both the soluble and mitochondrial forms of AAT from chicken heart as 
part of their isolation procedures. They added ammonium sulfate to a 
solution of either isozyme until a faint turbidity appeared. This 
precipitate was removed by centrifugation, and the solution was allowed 
to stand until crystals appeared, usually in a day or two. The crystals 
of neither enzyme were of the size or quality suitable for crystallogra­
phy. 
Koeppe et aj_. (1975) reported crystallization of pig heart 
cytosolic AAT by a pulsed diffusion technique which alternately pre­
cipitated and redissolved the enzyme by dialysis against concentrated 
and dilute solutions of 2-methyl-2,4-pentanediol. The crystals ob­
tained this way were not large enough for crystallography. 
Recently, three research groups have crystallized aspartate 
aminotransferase from different sources and have begun the crystallo-
graphic structure determination. Borisov et aj_. (1977) crystallized 
chicken heart cytosolic AAT as the a-methylaspartate complex by 
salting out with ammonium sulfate and cesium chloride in the presence 
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of a semipolar solvent. They have calculated an electron density map 
of the enzyme at 5 % resolution and have located the active site by 
means of a difference map of the crystalline apoenzyme (Borisov e;t 
al., 1978). They have also calculated difference maps of the PLP-
enzyme, PMP-enzyme, and the enzyme-isonicotinic acid complex against 
the a-methylaspartate complex. These difference maps showed large 
positive and negative peaks, indicating that those forms have a 
different conformation than the apoenzyme and the «-methylaspartate 
complex. More recently they have calculated an electron density map 
at 3.5 from which they were able to trace most of the poly­
peptide chain (Borisov j&t , 1979). 
Arnone e^ a^. (1977) crystallized pig heart cytosolic AAT by 
vapor diffusion against a solution of polyethylene glycol 6000 using 
the "sandwich box" technique of McPherson (1976). They have calculated 
an electron density map at 2.7 R resolution and have located the co­
enzyme and substrate binding sites by means of difference maps of the 
apoenzyme and of crystalline complexes with erythro-e-hydroxyaspartate 
and a-methylaspartate (Metzler e^ , 1979). 
Gehring e^ aj_. (1977a) have crystallized mitochondrial AAT from 
chicken heart by vapor diffusion against a solution of polyethylene 
glycol using the "hanging drop" method. They have calculated an 
electron density map at 3.2 X resolution from which they could trace 
the entire polypeptide chain in both subunits of the dimeric enzyme 
(Eichele e^ al_., 1979a). More recently they constructed a model of 
the active site of the enzyme based on a map at 2.8 % resolution 
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(Ford e;t , 1980). Jansonius and coworkers are also collecting 
data on mitochondrial AAT from pig hearts, which forms crystals iso-
morphous with crystals of the enzyme from chicken heart mitochondria 
(Eichele <^t 1979b). 
Absorption spectra of crystalline pig heart cytosolic AAT 
(Metzler e;t , 1978) and of chicken heart mitochondrial AAT (Eichele 
e^ al_., 1978) are being studied. Both enzymes are completely inter-
converted between the PLP and PMP forms by diffusion of appropriate 
substrates into the crystals. Both crystalline enzymes also show the 
absorption band of a quinonoid intermediate with g-hydroxyaspartate. 
Polarized light absorption spectra indicate that the coenzyme ring 
rotates during catalysis (Metzler e;t , 1978; Jansonius ej^ £1» » 1979), 
although not along the C-2 and C-5 axis as suggested by Ivanov and 
Karpeisky (1969) from circular dichroic spectra. 
Coenzyme Analogs 
The presence of the covalently-bound cofactor pyridoxal 5'-phos­
phate in the active site of aspartate aminotransferase gives an 
especially iseful tool for studying the active site of the enzyme. 
A large number of analogs of PLP have been synthesized in order to 
study the interactions of the coenzyme with the protein. The binding 
of these analogs to apoAAT is followed by absorption and circular 
dichroism spectroscopy, and any complexes that are formed are tested 
for enzymatic activity and for the inhibition of PLP binding. 
In such studies, it was found that, although N-methylpyridoxal 
phosphate and PLP N-oxide bound to the apoenzyme, a free ring nitrogen 
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is essential for catalysis. Similarly, analogs with an absent or 
modified 3'-hydroxyl group bind to apoAAT but are inactive. The 
4'-formyl group is essential for tight binding (formation of the 
enzyme-coenzyme Schiff base) and for enzymatic activity, although the 
4'-ethynyl analog of PLP appears to form a Schiff base by addition 
of an amino group of the protein to the ethynyl group of the coenzyme 
and rearrangement of the resulting enamine (Yang et a]_., 1975). The 
apoenzyme seems to have considerable spatial tolerance for substi-
tuents at the 2 and 6 positions of the coenzyme ring. 2-Nor-PLP, 
2'-methyl-PLP, 2',2'-dimethyl-PLP, 6-methyl-PLP, and 2-nor-6-methyl-PLP 
all bind stoichiometrically to the active site and produce complexes 
with enzymatic activities comparable to that of holoAAT (Braunstein, 
1973; Fonda, 1971; Furbish et , 1969; Yang e^ , 1975). 
The 5'-phosphate ester of PLP appears to be necessary for firm 
binding of the coenzyme to the enzyme and for effective catalysis, 
since most analogs modified at this position have little or no 
catalytic activity (Braunstein, 1973; Fonda, 1971; Furbish et al., 
1969). Analogs lacking the phosphate group do not inhibit apoAAT, 
even if they have alkylating groups at the 4'-position (Severin and 
Gulyaev (1976). Some analogs such as the 5'-trans-carboxyethenyl 
analog (Miura and Metzler, 1976) and pyridoxal 5'-sulfate (Yang 
e^ ^., 1974) inactivate apoAAT, becoming covalently bound. Mech­
anisms for these reactions have been proposed based on studies of 
model reactions. 
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Pyn'doxal 5'-sulfate 
Pyridoxal 5'-sulfate (PLS) is structurally quite similar to PLP 
since the sulfate and phosphate groups are both tetrahedral. The 
sulfur-oxygen bonds are only about 0.06 8 shorter than the phosphorus-
oxygen bonds, and the bond angles are almost identical. Chemically 
the two differ in that the esterified sulfate group lacks the second 
ionizable proton of the esterified phosphate. 
In spite of the structural similarities, PLS can act as a coenzyme 
with few of the PLP-requiring enzymes with which it has been tested. 
It does not bind to the apoenzyme of L^aspartate-g-decarboxylase (Tate 
and Meister, 1969). It binds to, but does not activate, mouse brain 
glutamate decarboxylase (Matsuda and Makino,1961), JE. coli glutamate 
decarboxylase (Likos, 1977), and D-serine dehydratase (Groman et al., 
1972). PLS does not form a stable complex with serine hydroxymethylase 
from rabbit liver, but excess PLS inhibits PLP binding to the apoenzyme. 
(Schirch and Schnackerz, 1978). In contrast, preliminary studies with 
the enzyme from sheep liver indicate that the apoenzyme can be partially 
reactivated with PLS (J.D. Cook and L. Davis, Department of Chemistry, 
University of Iowa, unpublished results). PLS induces the reassociation 
of the subunits of apophosphorylase, but the complex is inactive. 
(Shaltiel et , 1969). It binds very poorly to apotryptophanase, 
but the complex is slightly active. Arginine decarboxylase can be 
reconstituted with PLS ans regains 23% of the activity of the enzyme 
reconstituted with PLP (Groman et , 1972). 
The interaction of PLS with the apoenzyme of AAT has been studied 
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in detail (Yang e;t , 1974). PLS binds to the apoenzyme initially 
forming a Schiff base, but undergoes further reactions to become co-
valently bound to the protein. The complex has no measurable enzymatic 
activity. 
Pryidoxal sulfate reacts with a variety of amines and amino acids 
with nucleophilic substituents in the g-position in solution at pH 9. 
The spectral changes observed during these reactions were similar to 
those seen in the enzymatic reaction, so the reaction of PLS and cys­
teine was studied as a model for the enzymatic reaction. Based on the 
known reaction of pyridoxal phosphate and cysteine, the determination 
of free sulfate in the reaction mixture, and proton nmr, the reaction 
mechanism in Figure 3 was proposed. Pyridoxal sulfate (I) and cysteine 
react initially to form a Schiff base (II) and then a thiazolidine (III), 
in the same manner as PLP and cysteine react (Abbott and Martel 1 , 1970). 
However, the PLS-cysteine thiazolidine reacts further, losing a proton 
from the 4'-carbon of the coenzyme and eliminating sulfate to form a 
quinonoid intermediate (IV). This undergoes a prototropic shift to form 
a cyclic substituted Schiff base (V), which is the final product. The 
nmr spectra of the reaction mixture recorded at various times during the 
reaction substantiate this scheme, but also indicate that the reaction is 
not completely clean. Several spurious nmr peaks appear during the 
reaction and are present in the spectrum of the final product. 
It was proposed that a nucleophilic group at the active site of 
aspartate aminotransferase reacts with the Schiff base of PLS and the 
active center lysine in a similar reaction. 
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Figure 3 Proposed mechanism of the reaction of pyridoxal 5'-
sulfate with cysteine, a model for the reaction of 
pyridoxal sulfate with aspartate aminotransferase 
(Yang, e;t £l_., 1974). 
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MATERIALS 
Enzymes 
The a subform of pi y heart cytoplasmic aspartate aminotransferase 
was isolated in this laboratory by the method of Jenkins ejt (1959) 
as modified by Martinez-Carrion et al_. (1967b, Method A). The 
apoenzyme was prepared by the method of Scardi et (1963) as 
modified by Furbish et (1969). 
Pepsin, trypsin, and chymotrypsin were purchased from Worthington 
Biochemical Corp. Aminopeptidase M was purchased from the Pierce 
Chemical Co. 
Pyridoxal Phosphate Analogs 
Pyridoxal 5'-sulfate was prepared in this laboratory by Dr. 
Allen Cahill by the procedure of Yang et (1974). The 5'-trans-
carboxyethenyl analog of pyridoxal phosphate was synthesized by Dr. 
Retsu Miura (Miura and Metzler, 1976). 
Other Chemicals 
N-ethylmaleimide, £-chloromercuribenzoic acid, iodoacetamide, 
5,5'-dithiobis(2-nitrobenzoic acid),l-dimethylaminonaphthalene-5-
sulfonyl chloride (Dansyl chloride), dansyl-glutamate, dansyl-serine, 
dansyl-valine, dansyl-isoleucine, dansyl-arginine, s-dansyl-lysine, 
a,e-bisdansyl-lysine, pyridoxal 5'-phosphate, and pyridoxamine 5'-
phosphate were purchased from Sigma Chemical Co. Methyl mercuric 
chloride was obtained from Research Organic/Inorganic Chemicals. 
The tetrafluoroborate salt of diazotized sulfanilate was purchased 
29 
from Calbiochem-Behring Corp. 
All other chemicals were purchased from commercial sources and 
were of reagent grade or better. 
Dansyl-alanine, dansyl-glycine, dansyl-phenylalanine, 0-dansyl-
tyrosine, and N,0-bisdansyltyrosine were prepared from the correspond­
ing amino acids by the procedure of Gray (1972). 
30 
METHODS 
The concentration of aspartate aminotransferase was determined from 
the absorption of the solution at 35.8 kK (280 nm), using a molar 
absorptivity of 6.55 x 10^ M"^cm" for the holoenzyme and a molar 
absorptivity of 6.36 x 10^ for the apoenzyme (Furbish e;t a^., 1969). 
The concentrations refer to the monomer. 
Determination of Free Sulfhydryl Groups 
Free sulfhydryl groups of AAT were determined by titration with 
5,5-dithiobis(2-nitrobenzoate), DTNB, as described by Birchmeier et al. 
(1973a), using = 13600 Kr^cm"! for 5-thio-2-nitrobenzoate 
(Ellman, 1959). Protein with approximately 5 nmol sulfhydryl groups 
was added to 1.0 mL \% sodium dodecyl sulfate in 0.1 M sodium phosphate, 
pH 7.5, in a semimicro cuvette. After about 5 min, when the absorbance 
at 412 nm had reached a constant value, 10 wL of 40 mM DTNB in 0.1 M 
phosphate was added. The increase in the absorbance at 412 nm was 
followed on a Gilford-Beckman DU specrophotometer until it reached 
a maximum value in about 5 min. A second cuvette containing no pro­
tein was used to correct for the absorbance of DTNB. 
Modification of Sulfhydryl Groups 
Hereafter, "phosphate buffer" refers to 0.10 M sodium phosphate, 
pH 7.5, and "acetate buffer" refers to 0.04 M sodium acetate, pH 5.4. 
Sulfhydryl group modifications were performed in phosphate buffer 
at room temperature, unless otherwise specified. Modified proteins 
were separated from excess reagents and low molecular weight products 
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on a column of Sephadex G25 (1.1 x 35 cm) equilibrated with phosphate 
buffer if the protein was to be modified further, or with acetate 
buffer if it was to be crystallized directly. 
Cys45 and Cys82 of AAT were modified with N-ethylmaleimide (NEM) 
by the procedure of Birchmeier e^ • (1973a). AAT (2 x ICT^M monomer) 
was allowed to react with 2 mM NEM for 1 h. at room temperature. 
Modification of Cys45 and Cys82 with cyanide was accomplished in 
-4 two steps (Birchmeier et ^., 1973a). AAT (10 M) was first reacted 
with 0.4 mM DTNB to form a mixed disulfide between cysteine and 5-thio-
2-nitrobenzoate (TNB). The bound TNB was then displaced by adding 
solid KCN to a concentration of 10 mM. Both reactions could be 
followed spectrophotometrically by the increase in absorbance at 
412 nm due to the release of TNB". The first reaction was complete 
within 10 min; the second step took about 30 min. The modified 
protein was dialyzed overnight against acetate buffer to remove 
cyanide which had apparently formed an adduct with the coenzyme. 
AAT blocked at Cys45 with cyanide was prepared by first forming 
the TNB derivative by the procedure of Wilson e^ al_. (1974) and then 
"4 displacing the TNB with cyanide. AAT (10 M) mixed with an equi­
valent amount of DTNB in a spectrophotometer cell. The reaction was 
followed by the increase in absorbance at 412 nm until approximately 
0.96 equivalent of TNB" was released. Bound TNB was displaced by 
cyanide as described above. 
Cys45 and Cys82 were modified with iodoacetamide by the procedure 
of Critz and Martinez-Carrion (1977a). AAT (2 x 10"^M monomer) was 
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allowed to react with 0.4 M iodoacetamide in 0.1 M potassium phosphate, 
pH 6.0, at 4° for 24 h in the dark. 
S.yncatalytic modifications 
Cys390 of AAT blocked at Cys45 and Cys82 by NEM was modified 
syncatalytically in phosphate buffer containing 70 mM ^-glutamate, 
2 mM a-ketoglutarate, 1 mM PLP, and 1 mM PiMP (Birchmeier et al., 
1973a). The enzyme was reacted with either 0.11 mM ^-chloromercuriben-
zoate or 0.11 mM methyl mercuric chloride for 24 h at 4°. Excess reagents, 
substrates, and coenzymes were removed on a column of Sephadex G25 (1.1 
X 35 cm) equilibrated with acetate buffer. 
To prepare the cyanide derivative of Cys390, NEM-blocked enzyme 
was reacted with 0.12 mM DTNB for 24 h under the conditions for syn-
catalytic modification outlined above (Birchmeier et , 1973a). After 
the excess reagents were removed, solid KCN was added to about 10 mM 
to displace the bound TNB. 
To determine whether or not methylmercuric chloride binds to AAT 
modified at Cys45 and Cys82 under the conditions for crystallization, 
iodoacetamide-modified AAT (34.7 mg/mL) was incubated with 1.05 eq 
of methylmercuric chloride per monomer in acetate buffer for 2 h. 
Protein was separated from unreacted reagent on the Sephadex column 
before it was assayed for free sulfhydryl groups in the usual manner. 
Crystal 1ization 
Native and modi fed AAT's were crystallized by vapor diffusion 
against a solution of polyethyleneglycol, PEG (McPherson, 1976; Arnone 
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Êi. âi» » 1977). Each well in a glass spot plate contained 20 y.L protein 
solution at a concentration of 30-50 mg/mL in 0.04 M sodium acetate, 
pH 5.4, and 20 pL 8% (w/v) PEG 6000 in the same buffer. The reservoir 
in a Petri dish contained 25 rnL 8% PEG 6000 in the same buffer. The 
spot plate and reservoir were sealed in a plastic sandwich box with 
stopcock grease and set at 4° until crystals formed. 
To crystallize mercury derivatives of the various sulfhydryl 
groups of AAT, 20 pL of a solution of native or modified AAT con­
taining 120-200 nmol monomer was placed in a well with 20 pL 8% PEG 
6000 containing 1.05 equivalents of £-chloromercuribenzoate or of 
methyl mercuric chloride per sulfhydryl to be modified. Native AAT 
was set up with 1.05 or 2.1 equivalents of mercury per protein monomer 
in an attempt to prepare derivatives at Cys45 alone or at Cys45 and 
Cys82. AAT blocked at Cys45 with cyanide was used in an attempt to 
prepare a specific derivative of Cys82. AAT blocked at Cys45 and 
Cys82 with NEM, iodoacetamide, or cyanide was used in an attempt 
to prepare a derivative at Cys390. In all cases, the blocking groups 
were small and uncharged so that they would not disturb the structure 
of the protein nor interfere with intermolecular contacts in the 
crystal. 
Reactions of Pyridoxal Phosphate Analogs with ApoAAT 
ApoAAT (10"^M monomer) was modified with pyridoxal 5'-sulfate 
(PLS) or with the 5'-trans-carboxyethenyl analog in 0.02 M tri-
ethanolamine buffer, pH 8.3. ApoAAT was allowed to react with 
one equivalent of coenzyme which was added from a 10 mM stock 
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solution. The reaction with PLS was allowed to proceed for 2 h at 
room temperature, the reaction with the carboxyethenyl analog for 
20 h. 
The concentration of the product of the reaction of PLS with 
apoAAT was calculated from the absorbance of the chromophore at 
low pH at 26 kK, using £=5.3 x 10^ (Yang et £1_., 1974). 
Enzymatic digestions 
The solution of modified apoAAT was passed over a column of 
Sephadex G25 (1.1 x 30 cm) equilibrated with 0.01 M HCl. The 
fractions containing the modified protein were easily identified by 
the intense fluorescence of the products at low pH. 
The protein solution to be digested with chymotrypsin was adjusted 
to pH 7.3 with 0.5 M NaOH. Chymotrypsin, suspended in a small volume 
of water, was added in a 1/50 ratio by weight to the apoAAT. During 
the digestion the pH was maintained at 7.3 by a Radiometer TTTl 
Autotitrator used as a pH-stat. 
Digestion with pepsin was usually performed in 0.01 M HCl at 
pH 2.5. Pepsin was added from a freshly prepared solution of pepsin 
(10 mg/mL) in 0.02 M sodium acetate, pH 4.7, in a 1/100 ratio by 
weight to the apoAAT to be digested. After 1 h of digestion at room 
temperature, a second portion of pepsin was added in the same manner 
as the first, and digestion was allowed to proceed for 4 h longer. 
Digestion was terminated by the addition of a drop of pyridine, 
which raised the pH to above 5. The solution was then lyophilized. 
Alternatively, the reaction mixture of apoAAT and coenzyme 
35 
analog in triethanolamine buffer was acidified by the addition of 
1 M formic acid until the pH was lowered to 2.5. A solution of pep­
sin in .01 M formic acid was added in a 1/100 ratio by weight to 
the apoenzyme to be digested, and digestion was allowed to proceed 
at 37° overnight. 
Isolation of the modified peptides "• 
The lyophilized peptides from the pepsin digest of coenzyme-
modified apoAAT were suspended in a small volume of 0.10 M acetic 
acid and applied to a column of Sephadex G25 (0.7 x 120 cm) equili­
brated with 0.10 M acetic acid. An amount of digest representing 
up to 0.6 ymol AAT monomer could be applied at once and be separated 
adequately. Fractions of 0.8 to 1 ml were collected and the ab-
sorbances at 280 nm (35.8 kK) due to aromatic amino acids and at 
386 nm (26.2 kK) due to the PLS chromophore were recorded. 
Fractions that contained the PLS chromophore with a large number 
of other peptides were pooled, lyophilized, resuspended in about 1 mL 
of 0.10 M acetic acid, and applied to a column of Sephadex G15 
(1.1 X 120 cm) equilibrated with 0.10 M acetic acid. Again, fractions 
of 0.8 to 1 mL were collected and analyzed for absorbance at 280 nm 
and at 382 nm. 
In some preparations a single gel filtration step was used. The 
pepsin digest of up to 1.3 ymol of AAT was applied to a column of 
Sephadex G15 (2.2 x 120 cm). The peptides were eluted in 0.01 M 
formic acid. Fractions of 0.8 mL were collected and analyzed. 
Further purification was achieved by electrophoresis on thin layers 
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of Sephadex G25 in formic acid/acetic acid/water (1:4:45,v/v), pH 1.9, 
on a Desaga/Brinkman double chamber electrophoresis apparatus. Thin 
layer plates were prepared according to instructions from Brinkman-
Desaga. A thick slurry was prepared from 20 g Sephadex G25 superfine 
and 100 mL electrophoresis buffer. About 60 mL of the gel suspension 
was poured onto an extremely clean 40 x 20 cm glass plate, and spread 
to the edges with a glass rod. Two corners of the plate were lifted 
several cm above the bench and dropped to smooth minor irregularities 
in the gel layer. The resulting gel layer was smooth and shiny. It 
was left to air dry until it was quite dull but not cracked. 
The lyophilized sample, usually containing about 0.4 ymole PLS 
chromophore, was suspended in 20 yL 0.10 M acetic acid and applied to 
the dried gel layer in a line about 2 cm from the anode end. Electro­
phoresis was run at 800 v, 35 ma for 5 h or longer, until the fastest-
migrating fluorescent band approached the cathode end of the plate. 
Its progress was monitored periodically during the run with a UV lamp. 
After electrophoresis was terminated, the fluorescent bands were 
scraped from the plate. The gel was suspended in a small volume of 
0.1 M acetic acid and transferred to Pasteur pipets plugged with 
glass wool. The peptides were eluted from these columns with about 
10 mL of 0.1 M acetic acid. 
The final purification step was a second thin-layer electrophor­
esis at pH 4.7. The procedure was identical to that at pH 1.9, 
except that the gel buffer was 0.10 M ammonium acetate, pH 4.7. 
1.0 M ammonium acetate buffer was used in the electrode chambers to 
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reduce the electrolytic heating there. The electrophoresis was run 
at 600 V, 25-40 ma, for about 5 h. 
The peptides containing the carboxyethenyl chromophpre were separated 
by gel filtration on the Sephadex G25 column and thin layer electrophor­
esis at pH 1.9 in the same manner as the PLS peptides. 
At each step in the purification the samples were analyzed by 
high voltage paper electrophoresis at pH 1.9 and at pH 6.4. High 
voltage paper electrophoresis was done in the following way. For 
electrophoresis at pH 1.9, 5 uL of sample was applied in a narrow 
band 1 cm long along an origin line 15 cm from the anode end of a 
sheet of Whatmann 3MM paper, 46 x 57 cm. Without allowing the sample 
to dry, the paper was wetted with approximately 50 mL of pH 1.9 
electrophoresis buffer, the same as that used for thin-layer electro­
phoresis, and the excess was blotted off. Electrophoresis was run 
at 2500 V for 45 min. Electrophoresis at pH 6.4 was performed in 
much the same way except that the origin line was in the center of 
the paper, the buffer was pyridine/acetic acid/water (3:100:897, 
v/v/v), and the electrophoresis was run at 1500 v for 75 min. After 
electrophoresis the papers were dried in a hood, the fluorescent 
spots were marked, and the papers were stained first with Cd^^ -
ninhydrin stain (Yamada and Itano, 1966) and then with Ehrlich's 
stain for indole (tryptophan) (Zweig and Whitaker, 1969). 
Characterization of the isolated peptides 
Amino acid analysis of the purified peptides was performed on a 
Durrum D400 analyzer after hydrolysis of the peptides in 6 M HCl at 
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110° for 22 h. The amount of the PLS chromophore in each sample was 
determined from its absorbance at 382 nm at pH 3 using e= 5.3 x 10^ 
before the sample was hydrolyzed. 
The amino terminal residues were identified by dansylation and 
chromatography on polyamide sheets (Gray, 1972). Approximately 5 
nmol of peptide in 10 yL 0.2 M NaHCO^ was reacted with 10 yL dansyl 
chloride (2 mg/mL in acetone) for 1 h at 37°. The peptides were 
hydrolyzed in 50 yL 6N HCl in sealed tubes at 110° overnight. The 
hydrolyzed samples were dried in a vacuum desiccator over NaOH and 
PgOg, then suspended in 10 yL 50% pyridine. 5 yL of the sample was 
spotted on two polyamide sheets; reference dansylamino acids were added 
to one sheet. Chromatography was run first in HgO/HCOOH (200:3, v/v), 
then in acetic acid/benzene (1:9, v/v) perpendicular to the first 
ascent. A third ascent, in the same direction as the second, was run 
in ethylacetate/acetic acid/ethanol/water (500:34:34:20, v/v). After 
the second ascent and after the third, the positions of the fluorescent 
spots were recorded in order to identify the dansylated amino acid 
from each peptide. 
Digestion by aminopeptidase M, followed by high voltage paper 
electrophoresis or thin layer chromatography, was used to identify 
asparagine in an isolated peptide. A sample of peptide 4 containing 
100 nmol of the PLS chromophore was digested with 3.5 yg amino-
peptidase M in 0.15 M ammonium bicarbonate, pH 8, at 37° for 4.5 h. 
The digest was then subjected to high voltage paper electrophoresis 
at pH 1.9 and at pH 6.4 with serine, lysine, and asparagine standards. 
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A second sample of peptide 4, containing 25 nmol of PLS chromo-
phore, was digested with 5 yg aminopeptidase M for 4 h at 37°. The 
digest was separated by thin layer chromatography on silica in chloro-
form/methanol/17% NH4OH (2:2:1, v/v). 
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RESULTS 
Crystal]ographic Studies of Aspartate Aminotransferase 
The crystallography of cytosolic aspartate aminotransferase 
from pig hearts began when an exceptionally pure preparation of the 
enzyme crystallized on concentration. The purity of the enzyme is 
judged by the ratio of the protein absorbance at 280 nm to the PLP 
absorbance at 430 nm. A ratio of 9 is typical of most enzyme 
preparations, but the peak ratio of this preparation was 8.4. When 
the enzyme was being concentrated in 0.04 M sodium acetate, pH 5.4, 
by vacuum dialysis before being frozen for storage as usual, micro-
crystals formed. Because of the conical shape of the concentrator bag 
the protein became very concentrated in the tip where the crystals 
formed. The supernatant enzyme solution was taken to Arthur Arnone 
at the University of Iowa, and was set up to crystallize by the vapor 
diffusion technique of McPherson (1975). Large, well-formed crystals 
appeared within 3 to 5 days. Precession photographs of the diffraction 
0 
pattern revealed that the crystals diffracted to at least 2.8 A 
resolution. 
Modification of sulfhydryl groups 
The extent of modification of sulfhydryl groups of AAT by the 
various reagents are summarized in Table 1. Native AAT routinely 
showed 4.6 free sulfhydryls per monomer. Modification with iodo-
acetamide or NEM lefr 2.7 sulfhydryls per monomer, indicating that 
1.9 sulfhydryls were modified. Excess DTNB modified 2.1 sulfhydryls 
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Table I. Determination of the extent of modification of the sulfhydryls 
of aspartate aminotransferase. 
Modification free -SH -SH modified 
None 4.6±0.1 
Iodoacetamide 2.7±0.1 1.9® 
1 equivalent of MeHgCl 1.7±0.1 1.0® 
N-ethylmaleimide 2.7±0.2 1.9® 
MeHgCl (syncatalytic) l.OiO.l 1.7® 
pMB (syncatalytic) 1.3±0.1 1.4® 
0.4 mM DTNB 2.1^+0.1 
1 equivalent of DTNB l.O^iO.l 
^Determined by titration with DTNB after modification. 
^Determined by TNB" release during the modification reaction. 
per monomer of native AAT while 1 equivalent of DTNB per monomer 
reacted to completion. 
Addition of 1.05 equivalents of methyl mercuric chloride per 
monomer of iodoacetamide-blocked AAT resulted in the loss of 1.0 
free sulfhydryl per monomer. On the other hand, syncatalytic modi­
fication of NEM-blocked enzyme with either methylmercuric chloride 
or pMB resulted in the loss of more than one free sulfhydryl per monomer. 
Heavy atom derivatives of aspartate aminotransferase 
The crystals of native aspartate aminotransferase that are used 
for crystallography are well-formed chisel-shaped plates (Arnone 
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et , 1977). In order to give good data, the crystals must be at 
least 0.2 mm in the smallest dimension, but less than 1 mm, and have 
no flaws. Native AAT formed such crystals readily, but not the deri­
vatives. Most of the crystals I obtained from modified proteins were 
either small plates, needles, or large clumps of twinned plates. 
Native AAT crystallized with either 1 or 2 equivalents per monomer 
of methylmercuric chloride, and with a single equivalent of £-chloro-
mercuribenzoate. No crystals formed from AAT with 1 or 2 equivalents 
of mercuric acetate, or with 2 equivalents of mercuribenzoate. 
The cyanide derivative at cysteine-45 of AAT crystallized with 
no mercury reagent, and with 1 equivalent of methylmercuric chloride 
or mercuribenzoate, but did not crystallize with mercuric acetate. 
AAT modified at both cysteine-45 and cysteine-82 with cyanide 
crystallized with no mercury reagent and with methyl mercury, but not 
with mercuric acetate or with mercuribenzoate. 
Enzyme modified at the surface sulfhydryls with N-ethylmaleimide 
formed crystals with no mercury reagent, with methylmercuric chloride, 
and with mercuric acetate, but not with mercuribenzoate. A sample of 
NEM-modified AAT was modified syncatalytically with £-mercuribenzoate. 
Arnone and Rogers were not able to crystallize this derivative under 
the standard conditions, but did obtain small crystals in phosphate 
buffer at pH 7 by vapor diffusion. These crystals were not of the 
same crystal form as the native enzyme crystals, and so were not useful 
as a heavy atom derivative. 
AAT modified at the surface sulfhydryls with iodoacetamide 
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crystallized with no mercury reagent and with one equivalent per monomer 
of methyl mercuric chloride, £-chloromercuribenzoate, or mercuric 
acetate. 
Small plates of native AAT grown in the presence of two equiva­
lents of methylmercuric chloride, and of iodoacetamide-modified AAT 
grown with one equivalent of methylmercuric chloride showed intensity 
changes in their precession photographs, indicating that there was 
specific incorporation of mercury into the crystals. However, the 
crystals I obtained were too small to be used to collect data on the 
diffractometer. 
One good crystal was obtained of NEM-blocked AAT grown in the 
presence of 1.05 equivalents of methylmercuric chloride. The crystal 
formed in two weeks after it was set up. The crystal was square, 
about 0.4 mm on a side, with a long needle attached to one side 
and a small flaw in one corner. Paul Rogers removed the needle and 
the flawed part of the crystal before mounting it for data collection. 
The crystal gave an interpretable Patterson map at 4.4 K resolution 
(Figure 4) which showed there were one major and one minor mercury 
site in each monomer (Arnone and Rogers, personal communication). 
Crystallization of Apoaminotransferase 
A sample of aspartate aminotransferase was resolved by the usual 
method. The apoenzyme was passed over a column of Sephadex 625 
(1.1 X 35 cm) in acetate buffer, and was concentrated to 21.2 mg/mL. 
The apoenzyme was set up to crystallize under the usual conditions 
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Figure 4 Marker section (y = 0.5) of the NEM and methylmeçpury 
derivative of aspartate aminotransferase at 4.4 A 
resolution. The positions of the space group related 
vectors 1-1 and 2-2 are shown. The expected cross 
vector 1-2 appears as an intense peak on a y coor­
dinate of 0.395. (Courtesy of Arthur Arnone and Paul H. 
Rogers, Department of Biochemistry, University of Iowa,) 
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with small crystals of native AAT present for seeds in some of the 
wells. The seeds were transferred from the well where they had formed 
on a dissecting probe. The apoenzyme crystallized on each seed to 
give well-formed crystals. The seeds could be seen as yellow areas 
near the center of the crystals; the apoenzyme on the edges was color­
less. Several very small crystals consisting of only apoenzyme also 
formed in two of the wells with the seeded apoenzyme crystals. These 
crystals were used by Arnone and Rogers to seed additional set-ups of 
apoenzyme. A large well-formed crystal which grew from one of these 
apoenzyme seeds gave the diffraction data which was used in calculating 
a difference map of apoAAT versus native enzyme. A large negative 
peak was the outstanding feature of the difference map and clearly 
marked the position of the pyridoxal ring in the active site. The 
phosphate binding site in the crystal was not apparent, probably 
because a phosphate or sulfate ion was bound there (Martinez-Carrion, 
1975; Verge e^ aj_., 1979). 
Crystallization of other proteins 
A few attempts were made to crystallize other proteins that were 
available, but none were sucessful. In all cases the sandwich box 
technique was used, with vapor diffusion against solutions of poly­
ethylene glycol. 
The 3 and y subforms of AAT were set up to crystallize under the 
same conditions used for the a subform. The 3 subform at 40 mg/mL 
formed only microcrystals. Later, Carol Metzler was able to grow a 
large crystal of 3-AAT, which was determined to be isomorphous with 
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the a subform (Metzler ejt , 1978). The y subform did not 
crystallize when set up at 23.4 mg/mL, and eventually precipitated. 
D-Serine dehydratase, a pyridoxal enzyme isolated from coli, 
was set up at 51.3 mg/mL in 0.1 M phosphate, pH 7.8, against a variety 
of PEG solutions. 4%, 8%, and 16% PEG 6000, 4%, 8%, and 12% PEG 4000, 
and 8% PEG 20,000 were all used. No crystals were formed under any of 
the conditions used, and the protein eventually precipitated. 
Working with Louisa Tabatabai, I set up samples of phosphorylase 
kinase, 20 mg/mL in g-glycerol phosphate buffer, against 8% and 12% 
PEG 6000. The protein precipitated as soon as the PEG solution was 
added to each well. 
Modification of Aspartate Aminotransferase with Coenzyme Analogs 
Reaction of pyridoxal sulfate with modified apoenzyme 
Aspartate aminotransferase was modified at cysteine-45 and 
cysteine-82 with N-ethylmaleimide as described in Methods. Titration 
of the modified enzyme with DTNB revealed 2.8 sulfhydryls per monomer, 
compared with 4.8 sulfhydryls per monomer in the unmodified enzyme. 
The NEM-modified enzyme was syncatalytically modified with DTNB and 
cyanide to block cysteine-390. Titration of this protein with DTNB 
revealed 2.1 sulfhydryls per monomer, indicating that approximately 
70% of the enzyme molecules were modified at cysteine-390 with cyanide. 
A sample of AAT that was 50% modified with cyanide at cysteine-390 
retained 80% of the enzymatic activity of the enzyme modified by NEM 
at the surface sulfhydryls only. 
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Pyridoxal phosphate could be resolved from the syncatalytically 
modified enzyme by the usual procedure except that longer incubation 
times were found to be necessary for more complete resolution. When 
the standard procedure was used, the ratio of the protein absorbance 
at 280 nm to the PMP absorbance at 330 nm was only 17, whereas a ratio 
of 40 or greater is acceptable (Furbish e;t £!_• > 1969). When the 
incubation with 1 M phosphate was increased from 30 min to 3 h, the 
resulting apoenzyme had a ratio of 28. The spectrum of the modified 
apoenzyme (Figure 5) showed a small but unmistakable absorbance at 
330 nm, indicating that the enzyme was still not completely resolved. 
When a single equivalent of pyridoxal phosphate was added to the 
syncatalytically modified apoenzyme at pH 8.3, it was rapidly rebound 
to form a Schiff base absorbing at 363 nm, as with the unmodified apo­
enzyme. The absorbance at 363 nm reached a maximum within a few 
minutes and remained stable for at least 4 h. 
Pyridoxal 5'-sulfate reacted with syncatalytically modified 
apoAAT in the same way as it reacted with unmodified apoenzyme. The 
spectrum of the product of the reaction, shown in Figure 5, has the 
same peak position and the same narrow shape with pronounced vibronic 
fine structure as the product of the reaction of PLS with unmodified 
apoenzyme (Yang e^ a}^, 1974). 
Isolation of peptides modified by pyridoxal sulfate 
Enzymatic digestions Yang et (1974) reported that the 
chromophoric product of the reaction of PLS with apoAAT is unstable 
when the protein was denatured by guanidine hydrochloride at high pH. 
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Figure 5 The reaction of 9.5 x 10" M aspartate apoaminotrans-
ferase modified at cysteine-390 with cyanide with 
9.2 X 10"5 M pyridoxal sulfate. The numbers beside the 
curves indicate the time in minutes after mixing. The 
spectrum of the apoenzyme is also shown. 
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At pH 8.2 the absorbance at 402 nm disappeared overnight. The chromo­
phore was much more stable at low pH (pH 5 or below) than at higher pH. 
The low pH form of the chromophore was found to be stable for many 
days in 6 M guanidine hydrochloride. 
When the PLS-modified enzyme was denatured in 0.01 M HCl, then 
digested by trypsin at pH 7.3 for 5 h, the chromophore absorbance 
disappeared completely (Figure 6). The chromophore was also destroyed 
when digested by chymotrypsin or by a mixture of trypsin and chymn-
trypsin under the same conditions. 
Attempts were made to isolate a modified peptide from chymo-
tryptic digests on columns of Dowex 1-X2 eluted with pyridine-
col1idine-acetic acid buffers (Morino and Watanabe, 1969) and by 
paper chromatography and electrophoresis. Although there was no 
visible absorption spectrum that could be used to follow the PLS 
product, there was something in the digest with a blue-white 
fluorescence, which I supposed to be the PLS product. I attempted 
to follow this fluorescence through the separation procedure. These 
efforts were without success either in isolating a modified peptide 
or in identifying a PLS product. 
The low pH form of the PLS chromophore proved to be stable under 
the conditions for digestion by pepsin. When the modified enzyme 
was digested with pepsin at pH 2.5 for 5 h, there was a slight shift 
of the absorbance maximum of the PLS chromophore from 386 to 382 nm 
(25.9 to 26.2 kK) and only 4% decrease in the peak height (Figure 6). 
With the addition of base, the solution became turbid, but the 
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Figure 6 Enzymatic digestion of pyridoxal sulfate-modified aspar­
tate aminotransferase, a. 3.0 x 10"^ M apoAAT modified by 
PLS, digested with chymotrypsin (1:100 w/w) for 5 h at pH 
7.3. The pH was adjusted to 2.5 before the spectrum was 
recorded, b. 3.0 x 10"^ M PLS-modified apoAAT digested 
with pepsin (1:100 w/w) for 5 h at pH 2.5. 
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chromophore was converted to the species absorbing around 400 nm 
(Figure 7). 
Isolation of the modified peptides 
The lyophilized peptides that resulted from the digestion of 
PLS-modified AAT by pepsin were first fractionated on a column of 
Sephadex G25 (0.7 x 120 cm). An amount of digest representing up 
to 0.6 ymol of AAT monomer could be applied at once to this column 
and be adequately separated. The peptides were eluted from the column 
in 0.1 M acetic acid. Fractions of 0.8 ml were collected and the 
absorbances at 280 nm, due to aromatic amino acids, and at 382 nm, 
due to the PLS chromophore, were recorded. A typical elution profile 
is presented in Figure 8. The PLS-peptides were rather small, since 
they emerged from the column after the bulk of the material. Re­
covery of the PLS chromophore from the Sephadex column was 76%. 
The PLS chromophore was unaltered by gel filtration, as indicated 
by its spectrum (Figure 9). Furthermore, at pH 9, the chromophore 
changed to its form absorbing at 400 nm, with the characteristic 
narrow band. 
High voltage paper electrophoresis at pH 1.9 of aliquots of the 
G25 fractions that contained the PLS chromophore showed that they 
were quite heterogeneous and contained several fluorescent species 
(Figure 10). 
Fractions from the G25 column were pooled in three parts, rep­
resenting the leading edge, the center, and the tail of the peak of 
chromophore content as it emerged from the column. Each pool was 
52 
o 
Z l . O  24.0 27.0 
WAVENUMBER (kK) 
30.0 33.0 
550 500 4^0 4^0 3?Ô 350 
WAVELENGTH (nm) 
Figure 7 Absorption spectrum of PLS-modified apoAAT after digestion 
with pepsin, a. pH 2.5. b. pH 8.1. 
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Figure 8 Fractionation of the peptic digest of 0.6 wmol PLS-AAT 
on a column of Sephadex G25 (0.7 x 120 cm) equilibrated 
with 0.1 M acetic acid, a, Absorbance at 280 nm. 
b. Absorbance at 382 nm, due to the PLS chromophore. 
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Figure 9 Absorption spectrum of a fraction containing the PLS 
chromophore after initial fractionation of PLS-AAT 
peptides on Sephadex G25. a. At pH 3.1. b. At pH 
9.1. 
55 
& % % 0 Pi 6 8 
0 
0 ® 
0 0  
8 
o O 
i 
% 
CD 
© 
o 
O O 
'>222' «r^ ?' 
57 58 59 60 61 62 63 64 q 
fraction number 
Figure 10 High voltage paper electrophoresis at pH 1.9 of fractions 
from Sephadex G25 chromatography of the peptic digest 
of PLS-AAT. Each fraction (0.74 ml) was lyophilized 
and resuspended in 200 pL 0.1 M acetic acid. 5 pL 
aliquots were spotted for electrophoresis as described 
in Methods. ( C3 Ninhydrin spots, 4^^ Fluorescent 
spots.) 
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applied to a column of Sephadex G15 (1.1 x 120 cm) equilibrated 
with 0.10 M acetic acid. Again, fractions of 0.8 mL were collected 
and analyzed for absorbance at 280 and 382 nm. The elution patterns 
are shown in Figure 11. 
Only the early PLS fractions from the G25 column were routinely 
subjected to the G15 fractionation because they were especially 
heterogeneous. Because of the tailing of the PLS peak on this column, 
only about 60% of the chromophobe that was applied was usually 
recovered. 
After gel chromatography the peptides were purified by electro­
phoresis. Whatmann 3MM paper could not be used as the solid support 
for electrophoresis because it was not possible to recover material 
from the paper that showed the spectrum of the intact chromophore. 
Electrophoresis was run at pH 1.9, pH 4.7, or pH 6.4 with similar 
results: the chromophore could not be recovered. In one experiment, 
several samples of peptides that contained the chromophore were applied 
to a sheet of Whatmann 3MM paper that had been previously wetted with 
pH 1.9 electrophoresis buffer. Immediately after electrophoresis was 
stopped, the fluorescent spots were cut out and were eluted with 
0.1 M acetic acid. Thus the samples were never allowed to dry or to 
contact dry paper. In another experiment, PLS peptides were spotted 
on paper and eluted without electrophoresis. In either case, the eluted 
material did not show the spectrum of the intact PLS chromophore. 
The chromophore had been shown to be stable on Sephadex during 
gel chromatography, so a thin layer of Sephadex G25 superfine was 
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Figure 11 Elution patterns of peptide fractions from the Sephadex G25 
column rechromatographed on a column of Sephadex G15 (1.1 x 
120 cm) in 0.1 M acetic acid. Absorbance at 280 nm and at 
382 nm are indicated by the numbers beside the curves. 
A. Early fractions from the PLS chromophore peak on the 
G25 column. 
B. Center of the PLS chromophore peak. 
C. Trailing edge of the PLS peak. 
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used as the support for electrophoresis. 
Further purification was achieved by electrophoresis on layers 
of Sephadex G25, superfine, in formic acid/acetic acid/water (1:4:45, 
v/v), pH 1.9, on a Desaga/Brinkman double chamber electrophoresis 
apparatus. 
The sample was applied to the gel layer in a line about 2 cm from 
the anode end. Electrophoresis was run at 800 v, 35 ma, for 5 h 
or longer, until the fastest-migrating band with the fluorescence 
of the PLS chromophore approached the cathode end of the plate. Its 
progress was monitored periodically during the run with a UV lamp. 
Material that eluted as a single peak from the Sephadex G25 
column gave at least four bands with the white fluorescence of the 
PLS chromophore on electrophoresis at pH 1.9 (Figure 12). These 
bands were assigned numbers 1 through 4, in order of increasing 
mobility toward the cathode. 
Immediately after electrophoresis was terminated, the areas of 
the gel that were fluorescent were scraped off the plate. The peptides 
were eluted from the gel samples with 10 to 15 ml 0.10 M acetic acid 
in Pasteur pipettes plugged with glass wool. 
The material eluted from each of the fluorescent bands had an 
absorbance peak at 26 kK, so the chromophore could be at least 
partially recovered after thin layer electrophoresis. 
Fractions 1 and 3 contained only small amounts of the chromophore, 
typically 2 to 3% of the amount that had been applied to the gel. These 
fractions were not obtained in sufficient quantity to permit further 
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Figure 12 A typical pH 1.9 electrophoresis plate under UV light 
The origin line (cj)), the anode (e), and the cathode ^ 
are indicated, along with the numbers assigned to the 
fluorescent bands. 
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purification, and paper electrophoresis showed that they each contained 
more than one peptide. Indeed, fraction 1 sometimes appeared to con­
tain two fluorescent bands on the thin layer gel. 
Fraction 4 contained 10 to 20% of the applied chromophore, 
while fraction 2 contained 20 to 30%. This was estimated from the 
absorbance at 26.2 kK of the material eluted from these bands after 
it had been concentrated to dryness on a rotary evaporator and taken 
up in a known volume of 0.1 M acetic acid. Samples that originated 
from the early PLS fractions from the Sephadex G25 column yielded more 
PLS chromophore in fraction 2 than fraction 4, while the center and 
tail of the G25 peak gave approximately equal amounts of chromophore 
in 2 and 4. 
High voltage paper electrophoresis of a portion of fraction 4 
at pH 1.9 gave a single intense fluorescent spot that stained 
faintly with ninhydrin, but was negative with Ehrlich's reagent for 
tryptophan. On electrophoresis at pH 6.4, two ninhydrin-positive 
spots appeared on the cathode side of the origin line, indicating that 
the PLS peptide was not completely pure. The more intense ninhydrin 
spot corresponded to the single fluorescent spot (Figure 13A and B). 
On high voltage paper electrophoresis at pH 1.9, fraction 2 gave 
a single highly fluorescent spot that stained strongly with ninhydrin 
and that also reacted positively with Ehrlich's stain for tryptophan. 
Electrophoresis at pH 6.4 gave two spots, one highly fluorescent spot 
that had migrated a short distance toward the anode and that reacted 
strongly with both ninhydrin and Ehrlich's stain, and a faintly 
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2 and fj^ction 4 from thin-layer electrophoresis at pH 
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fluorescent spot on the cathode side that gave a faint ninhydrin 
spot (Figure 13A and B). 
The spectrum of fraction 2 is shown in Figure 14. The absorbance 
at 382 nm of the PLS chromophore was present at low pH. In addition, 
there was a prominent peak at 280 nm that had the position and shape 
characteristic of tryptophan (Metzler e;t , 1972). When the 
concentration of tryptophan was calculated from the absorbance at 
35.8 kK using e=5.57 x 10^ (Metzler e^ , 1972), it was found that 
tryptophan was present in different preparations at four to five times 
the concentration of the PLS chromophore. 
The tryptophan-containing peptides and the PLS product were 
separated by a second thin layer electrophoresis in 0.1 M ammonium 
acetate at pH 4.7. The PLS chromophore was present in the most 
rapidly migrating fluorescent band. Tryptophan was in a slower-
moving band that could be seen as a faintly yellow fluorescent band 
about half-way between the PLS and the origin. The yield of the 
chromophore was about 48% of the amount that was applied. 
On high voltage paper electrophoresis at pH 1.9, the purified 
peptide 2 again gave a single fluorescent spot that was ninhydrin-
positive, but was negative with Ehrlich's stain. Electrophoresis at 
pH 6.4 gave only one spot on the cathode side of the origin which 
was fluorescent and stained faintly with ninhydrin. The spot seen 
previously on the anode side was no longer present. 
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Characterization of the isolated peptides 
Peptides isolated by electrophoresis Samples of peptide 2 
and peptide 4 were isolated by a combination of gel chromatography and 
thin-layer electrophoresis, as described above. 
Spectra of the chromophore The spectrum of peptide 4 
is shown in Figure 15. At pH 3.0, the spectrum showed a peak at 
382 nm, with a narrow spike at 281 nm. When the pH was raised to 
10.4 by the addition of NH^OH, the chromophore peak shifted to 400 
nm, as it does in the intact protein. The spike at 281 nm was no 
longer present, as the absorbance generally increased below 350 nm. 
At pH 10.4, the chromophore peak diminished in a first-order process 
with ti=20 min (Figure 16). Accompanying the decrease at 400 nm 
' 2  
were an increase around 310 nm and a small decrease around 280 nm. 
The spectrum of the final product had no identifiable peaks in the 
region of 500 to 250 nm. 
The spectrum of peptide 2 is shown in Figure 17. The PLS 
chromophore peak at 382 nm was present, as in Figure 14 , but the 
tryptophan spectrum was not. This was expected, since the purified 
peptide did not react with Ehrlich's stain (see Figure 13). The 
PLS peak shifted to 400 nm when the pH was raised to 10, as it did 
in the intact protein and in peptide 4. The chromophore of peptide 
2 was unstable at pH 10, and its spectrum decayed (Figure 18) in 
the same manner as the chromophore of peptide 4. Again, the spectrum 
of the final product had no identifiable peaks in the region of 500 
to 250 nm. The rising absorbance in the ultraviolet region of the 
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Figure 15 Spectrum of fraction 4 from thin-layer electrophoresis at 
pH 1.9. a. pH 3. b. pH 10.4. 
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Figure 16 Decay of the PLS chromophore of peptide 4 at pH 10. The 
numbers beside the curves indicate the time in minutes 
after the addition of NH4OH to raise the pH from 3 to 10. 
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spectrum is probably due to contamination. The peak at 240 nm does 
not correspond to any aromatic amino acid. 
A sample of fraction 2 from thin layer electrophoresis at pH 1.9 
was incubated at pH 10 until the PLS chromophobe absorbance at 400 
nm was destroyed. On high voltage paper electrophoresis at pH 1.9, 
the treated peptide had the same migration as the untreated PLS peptide 
and the tryptophan peptide. At pH 6.4, the treated PLS peptide 
migrated with the untreated peptide (Figure 19). Although the PLS 
chromophore is altered by base treatment, it apparently remains 
attached to the peptide. 
Amino acid analysis The results of the amino acid analysis 
of samples of peptide 2 and peptide 4 that were isolated by gel 
chromatography and electrophoresis are given in Table 2. The amount 
of the PLS chromophore in each sample was calculated from the absorbance 
at 382 nm, using e=5.3 x 10^ (Yang et , 1974). 
Peptide 2 contained aspartate, serine, glycine, leucine, phenyl­
alanine, and lysine in amounts approximately equal to the amount of 
PLS chromophore. Glutamate, alanine, valine, and isoleucine were 
also present as significant contaminants but at less than half the 
amount of PLS. 
Peptide 4 contained only 3 amino acids: aspartate, serine, and 
lysine. The yields of these amino acids were almost equivalent to 
the calculated content of PLS chromophore. The most significant 
contaminants were glycine, valine, tyrosine, and arginine, but the 
yields of these amino acids were less than half the amount of PLS 
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Figure 19 Fraction 2 from thin-layer electrophoresis at pH 1.9. 
untreated. 2:  treated with base to destroy the PLS 
chromophore. A. Electrophoresis at pH 1.9. B. Electro­
phoresis at pH 6.4. 
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Table 2. Amino acid analysis of peptide 2 and peptide 4 isolated 
by gel chromatography and thin layer electrophoresis. 
Peptide 2 Peptide 4 
amino nmol relative to PLS nmol relative to 
acid 
asx 76 1.0 18 .9 
thr 3 .04 1 .15 
ser 86 1.2 17 .9 
glx 32 .43 6 .3 
pro — " - - - -
gly 84 1.1 8 .4 
ala 32 .44 3 .2 
cys 
val 24 .33 7 .4 
met - - — - — — 
ile 26 .35 4 .2 
leu 74 1.0 2 .1 
tyr 2 .03 6 .3 
phe 71 .96 
lys 60 .82 18 .9 
his — — — — 
arg 5 .3 
trpG — — — — 
PLSb 74 1.0 20 1.0 
a Not detected in the absorbance spectrum at 280 nm. 
^Calculated from the absorbance at 382 nm at pH 3, using 
£=5.3 X 10^ (Yang e;t 3%., 1974). 
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chromophore. 
Amino terminal analysis Amino terminal analysis was per­
formed on samples from the same peptide preparations that were used for 
amino acid analysis in Table 2. The results indicated that serine 
was the amino terminal residue in each peptide, but that peptide 4 
was not completely pure. N-Dansylserine was the most intense spot 
in each chromatogram. Each chromatogram also contained two intense 
spots that were identified as dansyl-NH2 and dansyl-OH. The chroma­
togram of peptide 4 contained two additional spots which, from their 
positions and colors, were identified as N-dansylvaline and 0-dansyl-
tyrosine. Both valine and tyrosine were indicated in the amino acid 
analysis (Table 2) as significant contaminents. 
Alternative isolation procedure Robert D. Scott later found 
that the PLS peptides could be isolated on a large scale in good yield 
by chromatography on Sepharose P2, TLC on silica gel in butanol/acetic 
acid/water (4:1:1 v/v) and thin-layer electrophoresis at pH 1.9. We 
isolated peptides 2, 3, and 4 in this manner from 4.5 ymol PLS-
modified AAT. I analyzed these peptides with the following results. 
Amino acid analysis The amino acid analysis of peptides 
2, 3, and 4 are presented in Table 3. The amino acid contents of 
peptide 2 and of peptide 4 are in agreement with those in Table 2. 
Each peptide contains aspartate, serine, and lysine. In addition, 
peptide 3 contains phenylalanine, and peptide 2 has glycine, phenyl­
alanine, and leucine. The amounts of the contaminating amino acids are 
lower than in Table 2, and are less than 20% of the PLS content in 
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Table 3. Amino acid analysis of peptides 2, 3, and 4 isolated by 
gel chromatography, TLC, and TIE. 
amino 
peptide 2 peptide 3 peptide 4 
acid relative to PLS relative to PLS relative to PLS 
asx 1.2 1.0 1.2 
thr 0.1 — — 0.04 
ser 1.1 1.0 1.0 
glx 0.2 0.1 0.05 
pro —  —  
gly 1.1 —  —  0.1 
ala 0.2 0.04 0.05 
cys 
val 0.1 —  —  
met —  —  —  —  —  —  
ile 0.1 —  —  —  —  
leu 1.0 —  —  —  —  
tyr — —  —  
phe 1.0 0.9 
lys 0.6 0.5 0.6 
his 0.4 0.3 
arg 0.1 — - —  —  
trpG — — —  —  —  —  
PLSb 1.0 1.0 1.0 
^From absorbance at 280 nm (35.8 kK) See Figure 20. 
^Determined from absorbance at 382 nm (26.2 kK), using e=5.3 x 10^ 
M'^cm"! (Yang e;t , 1974). See Figure 20. 
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all cases except histidine. The amino acids for which no value is 
given were all less than 10% of the PLS content. 
Spectra of the isolated peptides The spectrum of each 
of the isolated peptides is shown in Figure 20. These spectra all 
have the same appearance as the spectrum in Figure 15. The spikes 
at 281 nm are all lower relative to the 382 nm peak than the spike 
in Figure 15, as there is generally less absorbance in the ultraviolet 
region. 
N-terminal analysis Samples of peptides 2, 3, and 4 were 
analyzed for the amino terminal residue by dansylation and thin-layer 
chromatography. Peptide 2 (Figure 21A) gave N-dansylserine as the 
major amino acid product, plus a small amount of N-dansylaspartate. 
The aspartate content of this peptide was rather high, so this may 
reflect a small contaminant. Peptide 3 (Figure 21B) showed N-dansyl-
phenylalanine and N^-dansyllysine. Peptide 4 (Figure 21C) gave N-
dansylserine as the major amino acid product, plus a negligible amount 
of N-dansylglycine. An error was made during the chromatography of 
the samples from peptide 2 and peptide 3, so that their chromatograms 
are different from that of peptide 4. However, standards were run in 
parallel with each sample, so that the results are interpretable. 
All the samples showed dansyl-NH^ and dansyl-OH, which are the reaction 
products of dansyl chloride with ammonia and water, respectively. In 
addition, each sample had an orange spot that migrated with the sol­
vent front on the third ascent. 
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Figure 21A Thin-layer chromatography of dansyl amino acids from 
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fluorescence. Orange fluorescence.) Peptide 2. 
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Asparaqine Two separate samples of peptide 4 were 
digested with aminopeptidase M. This peptidase cleaves proteins 
and peptides to free amino acids without converting amide residues 
to carboxylic acids, as acid hydrolysis does. After digestion one 
sample was subjected to high voltage paper electrophoresis at pH 1.9 
and at pH 6.4 along with standards of asparagine, lysine, and serine. 
The results are shown in Figure 22. The two major ninhydrin spots are 
serine and asparagine, but the lysine spot was much less intense than 
these two. There were three additional spots, one of which corres­
ponded to a faint fluorescence. These spots may have been the products 
of incomplete digestion, or contaminants. The fluorescent and nin­
hydrin spot may have been a single modified lysine in very low yield. 
The second sample of peptide 4 that had been digested with amino-
peptidase M was analyzed by thin-layer chromatography (Figure 23). 
The three ninhydrin spots corresponded to lysine, asparagine, and 
serine. Thus peptide 4, and presumably also peptide 2 and peptide 3, 
contains asparagine rather than aspartic acid. 
Histidine Because the amino acid analyses of several 
samples of PLS peptides indicated that histidine was present as a 
significant contaminant, the histidine content of a sample of peptide 
3 was determined independently by reaction with Pauly's reagent for 
imidazole (Ray, 1967). The amino acid analysis of this peptide 
(Table 3) included 0.3 mol histidine per mol PLS. A 62-nmol sample 
of peptide, which should have contained 19 nmol histidine, in 2 mL 
of water was reacted with 0.5 mL of 0.4% diazotized sulfanilic acid 
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Figure 23 Thin-layer chromatography of peptide 4 after digestion by 
aminopeptidase M. Chromatography was run on a silica gel 
plate in chloroform/methanol/17% ammonia (2:2:1, v/v). 
4_: Digest of peptide 4. Std: standard of serine, lysine, 
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in 10.8% sodium carbonate. The resulting absorbance at 510 nm 
was compared to a standard curve prepared from solutions of histidine. 
The absorbance at 510 nm of the peptide sample corresponded to a 
total of 5 nmol of histidine. This is much less than the amino acid 
analysis indicated. The reaction of diazotized sulfanilic acid with 
histidine standards was not instantaneous. The absorbances reached 
a maximum value in about 2 min. However, the absorbance of the 
peptide sample did not change in this time. Since Pauly's reagent 
reacts with phenol as well as imidazole, the small absorbance may 
have been due to the reaction of the reagent with the phenolic 
hydroxy! of PLS and the sample may contain no histidine at all. 
Attempts to obtain a smaller modified peptide After digestion 
of peptide 4 with aminopeptidase M for 4 h at pH 8, the spectrum 
of the PLS chromophore was no longer observed. This was expected, 
since the chromophore was known to be unstable at this pH. On the 
other hand, incubation of a mixture of PLS peptides with amino-
peptidase M at pH 5.9 overnight did not alter the electrophoretic 
mobilities of the peptides. Therefore, it seems that the peptidase 
is not active in the pH range where the PLS chromophore is stable, 
and that it is not possible to obtain a smaller modified fragment 
by this means. 
In the same manner, digestion of a mixture of PLS peptides 
with pepsin at 37° overnight did not change the electrophoresis 
pattern of the sample. It had been hoped that this treatment might 
convert all the PLS peptides to the smallest peptide, peptide 4. 
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Peptides modified by the carboxyethenyl analog 
ApoAAT was modified by the 5'-trans-carboxyethenyl analog of 
PLP (Miura and Metzler, 1975). The modified enzyme was digested 
with pepsin under the same conditions used for the digestion of the 
enzyme modified by PLS. The absorption of the low-pH form of the 
chromophore at 395 nm (25.3 kK) was almost unchanged upon digestion 
by pepsin. At pH 9, the chromophore converted to its form absorbing 
at 412 nm (24.3 kK). These spectra are shown in Figure 24. 
The whole digest was fractionated on a column of Sephadex G25 
(0.7 X 120 cm). The elution pattern is shown in Figure 25. Com­
parison of Figure 25 and Figure 8 reveals great similarity. Not 
only are the absorbances at 280 nm similar, but the chromophore-
containing peptides emerge from the column at the same position. 
The fractions that contained the chromophore of the analog were 
pooled, concentrated, and subjected to thin layer electrophoresis 
at pH 1.9, along with a similar sample of PLS-containing peptides. 
The yellow fluorescent peptides of the carboxyethenyl analog sample 
migrated approximately the same distances as the white fluorescent 
PLS peptides. The number and relative intensities of the fluorescent 
bands were the same: bands 2 and 4 were the major bands, and bands 
1 and 3 were less intense. The peptides containing the carboxy­
ethenyl analog were not recovered from this step in sufficient 
quantity to permit further characterization. 
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Figure 24 Spectrum of apoAAT modified by the carboxyethenyl analog 
after digestion by pepsin, a. pH 2.4. b. pH 9. 
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Figure 25 Fractionation of the peptic digest of apoAAT modified by 
the carboxyethenyl analog on a column of Sephadex G25 
(0.7 X 120 cm) in 0.1 M acetic acid. Absorbance at 
280 nm and at 395 nm (25.3 kK) are indicated by the 
numbers beside the curves. The arrow marks the peak of 
PLS peptides on the same column. 
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DISCUSSION 
Crystal!ographic Studies of Aspartate Aminotransferase 
The crystallization of aspartate aminotransferase in a form suit­
able for X-ray crystallography has opened a large and important field 
in the study of this enzyme. With the structure of the enzyme 
almost in hand, it will soon be possible to learn many new details 
about its means of catalysis. Because it is possible to obtain 
isomorphous crystals of a number of enzyme-substrate and enzyme-
inhibitor complexes (Metzler et al_., 1978), it will be possible to 
detect changes that occur in the structure of the enzyme between 
stages in the catalytic cycle. There is a large body of evidence 
that suggest that such changes occur -- syncatalytic modification 
of cysteine-390 (Birchmeier e;t aj_., 1973a), changes in the number 
of exchangeable protons (Pfister e^ , 1978), polarized light 
absorption spectra of crystalline enzyme-substrate complexes 
(Metzler et , 1979) -- but soon we will be able to see what the 
changes are. 
The several isozymes of aspartate aminotransferase are the 
only pyridoxal phosphate enzymes whose structures are known, other 
than phosphorylase where the function of the coenzyme is not known. 
Therefore these enzymes will be a model for the interactions of the 
protein, the coenzyme, and the substrate during catalysis. The 
crystallographic studies may also provide insights into the methods 
of catalysis by enzymes in general. 
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Crystal 1ine heavy atom derivatives 
The most successful method of preparing crystalline heavy atom 
derivatives of proteins has been to soak crystals of the native 
protein in solutions of the heavy atom reagent. The heavy atom 
reagent diffuses through solvent channels in the protein crystal to 
suitable binding sites. The resulting crystals are likely to be 
isomorphous with the native crystals, but the heavy atom sites are 
often non-specific and disordered. An alternative technique, which 
I used, is to react the protein in solution with a heavy atom reagent 
which forms covalent bonds with the protein, and then to crystallize 
the modified protein. This technique is often unsuccessful because 
the heavy atom reagent changes the structure of the protein or alters 
interactions between protein molecules so that the modified protein 
will not crystallize or form crystals that are not isomorphous with 
crystals of the native protein. However, with the methylmercury 
derivative of aspartate aminotransferase, this method works well. 
Native AAT, AAT modified at cysteine-45, and AAT modified at 
cysteine-45 and cysteine-82 all crystallized in the presence of one 
or more of the mercury reagents that were tried. Methylmercury 
derivatives were the most readily crystallized, but mercuribenzoate and 
mercuric acetate derivatives crystallized in some cases as well. 
Most of the crystals that formed for me were too small or too irregular 
to be used for crystallography, but the fact that they formed at all 
is encouraging. Using small crystals of native AAT as seeds, it should 
be possible to grow larger crystals of these heavy atom derivatives. 
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The crystal of NEM-modified AAT that was grown in the presence 
of one equivalent of methylmercuric chloride per protein monomer was 
the first good heavy atom derivative crystal of AAT. This crystal 
gave an interpretable Patterson map, indicating that there were a 
limited number of heavy atom sites in the unit cell. The peaks in 
the section of the Patterson map of this crystal, shown in Figure 4, 
are from the two major sites in each dimer. The two minor sites 
had a much lower occupancy, and so did not show up clearly. 
The Patterson function represents a map of interatomic vectors. 
A peak in the Patterson map has a weight proportional to the number 
of electrons in the two atoms represented by that peak. This means 
that vectors between pairs of heavy atoms give strong peaks in the 
Patterson map. However, since N heavy atoms in a unit cell give rise 
to peaks in the Patterson map, it is important to have only a few 
specific heavy atom sites (Blundell and Johnson, 1976). 
A Marker section (Figures 4 and 26) is a section of the Patterson 
map where vectors between symmetry-related heavy atoms appear. For 
the space group P2iZi2^ there are three Marker sections, at x=0.5, 
y=0.5, and z=0.5. The Marker section y=0.5, calculated at 3.5 X 
resolution for a crystal of native AAT grown in the presence of two 
equivalents of methylmercuric chloride per monomer, is shown in 
Figure 26. There are four peaks of differing intensities in this 
section, indicating that there are two major and two minor mercury 
sites on each dimer. A diagram of the relative positions of these four 
sites is shown in Figure 27. The distances from sites A to B and 
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Figure 26 Marker section (y=0.5) of a crystal of native aspartate 
aminotransferase containing two equivalents per monomer 
of methyl mercuric chloride. (Courtesy of Arthur Arnone 
and Paul H. Rogers, Department of Biochemistry, University 
of Iowa.) 
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Figure 27 Calculated distances between mercury sites in a crystal 
of aspartate aminotransferase containing two equivalents 
of methyl mercuric chloride per protein monomer. (Courtesy of 
Arthur Arnone and Paul H. Rogers, Department of Bio­
chemistry, University of Iowa.) 
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from A' to B', and from A to B' and A' to B are in agreement within 
experimental error. This shows that there are two pairs of equivalent 
mercury sites in the dimer related by a two-fold axis of symmetry 
(A. Arnone and P.H. Rogers, personal communication). 
It had been supposed that mercury reagents, such as methyl-
mercuric chloride and £-chloromercuribenzoate, would react with the 
sulfhydryl groups of AAT in the same order as other sulfhydryl 
reagents: cysteine-45 first, then cysteine-82, cysteine-390 under 
syncatalytic conditions or at low pH, cysteine-191 and cysteine-252 
only under denaturing conditions (Wilson et ^., 1974; Zufarova 
et , 1973). However, Rogers and Arnone found that the same major 
and minor sites were occupied by methyl mercury whether or not cysteine-
45 and cysteine-82 were previously blocked by NEM. As the polypeptide 
chain was traced the major methylmercury site was identified as 
cysteine-191 and the minor site as cysteine-82. NEM was supposed 
to have blocked cysteine-82, as well as cysteine-45, but less than 
two sulfhydryls per monomer were lost during the incubation with 
this reagent (Table 1). A fraction of these residues must have 
remained unmodified and available to methylmercury. The occupancy 
of this site in the crystals of NEM-modified AAT was very low. 
P.H. Rogers and A. Arnone have grown well-formed crystals of 
AAT in the presence of more than two equivalents of methylmercuric 
chloride per monomer, but the crystals were not stable and cracked 
when they were warmed to room temperature. It is therefore not 
possible at this point to say whether methylmercury can be forced 
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onto additional sites or not. Rogers and Arnone have also obtained 
good crystals of AAT modified with £-chloromercLiribenzoate. There 
are two sites for this reagent. The major site has been identified 
as cysteine-82, which is the minor site for methyl mercury, and the 
minor site is cysteine-45. Although syncatalytic modification of 
cysteine-390 remains an attractive possibility, it has not yet 
given any suitable crystals. 
Locations of reactive residues 
An electron density map at 2.7 K resolution has been calculated 
using the methylmercury and ^-mercuribenzoate derivatives. Most of 
the polypeptide chain has been traced on this map, partially by 
comparing it to the published structure of mitochondrial AAT 
(Eichele et , 1979a). 
From the map at 2.7 X resolution, the methylmercury and £-mercuri-
benzoate sites listed above were identified. Cysteine-191, the major 
methylmercury site, is located on a bend at the end of a 3-strand, 
buried within the protein. Its location in such a rigid structure 
explains why this residue was not accessible to most sulfhydryl 
reagents except in the denatured protein (Wilson et aj_., 1974; 
Polyanovsky et , 1973a; Zufarova e_t , 1973). The small size 
of methylmercury and the nonpolar nature of its methyl group must 
enable this reagent to penetrate into the hydrophobic core of the 
protein. 
Methylmercury and £-mercuribenzoate both bind to cysteine-82. 
This residue is located in a pocket on the surface of the protein. 
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Methyl mercury binds between cysteine-82 and threonine-81, while 
mercuribenzoate binds in the midst of cysteine-82, arginine-85, 
and leucine-310. The leucine and arginine residues may be interacting 
with the aromatic ring and carboxyl group of the reagent, or mercuri­
benzoate may bind in this location in order to be oriented toward 
the solvent where there is room for its large benzoic acid moiety. 
The minor mercuribenzoate site, cysteine-45, is also located on 
the surface of the protein. The mercury position is in the solvent 
with threonine-42 and possibly tryptophan-48 nearby. 
Many researchers have drawn inferences about the structure of 
AAT from indirect evidence such as the reactivity of a residue, or 
the behavior of a paramagnetic or fluorescent group attached to a 
residue. In general, these predictions have been quite accurate. The 
locations of the five cysteine residues of AAT in the electron density 
map confirm the earlier proposals. Cysteine-45 and cysteine-82 are 
located on the surface of the protein, cysteine-390 is located near 
the active site, cysteine-191 and cysteine-252 are located on the 3 
wall, buried in the core of the protein (Zufarova e^ , 1973; 
Polyanovsky et a^., 1973a; Wilson e;t , 1974). Polyanovsky et al. 
(1973b) and Polyanovsky and Misharin (1974) calculated that cysteine-45 
and cysteine-82 were about 2.0 to 2.3 nm apart and that each was about 
2.5 nm from the active site. In the electron density map, cysteine-45 
is located more than 3 nm from cysteine-82, but is only about 2.7 nm 
from cysteine-82 of the other subunit of the dimer. Cysteine-45 
and cysteine-82 are about 1.7 and 2.1 nm, respectively, from the 
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active site. 
Deev ^ (1978) concluded that cysteine-390 and tyrosine-70 
must be about 0.5 nm from the e-amino group of lysine-258, since 
difluorodinitrobenzene crosslinks lysine-258 with either of the other 
two residues in apoAAT. Tyrosine-70 of the other subunit of the 
dimer is 0.5 nm from lysine-258, but cysteine-390 is about 1.0 nm 
away. Boettcher and Martinez-Carrion (1978) calculated that a 
paramagnetic probe attached to cysteine-390 was about 0.8 to 0.9 
nm from the coenzyme. This is reasonable in view of the location of 
cysteine-390 in relation to the active site. 
Two arginine residues, residue 386 of the subunit that forms the 
major part of the active site and residue 292 of the other subunit 
of the dimer, are located at either end of the binding site for 
a-methylaspartate. However, from the 3.0 % map it is not possible 
to tell which binds the w-carboxyl of the substrate, as proposed 
by Gilbert and O'Leary (1975). Khomutov et (1969) found 
evidence of a threonine residue near the phosphate of the coenzyme. 
In the electron density map threonine-109 is located close to 
the phosphate and probably forms a hydrogen bond to it. 
Ivanov and Karpeisky (1969) concluded from studies of the 
circular dichroism of the enzyme that a tyrosine residue formed a 
hydrogen bond to the ring nitrogen of PLP. The electron density 
map denies this possibility. The ring nitrogen is bonded to aspar-
tate-222. Tryptophan-140 is located near the coenzyme ring and may 
be the residue that is perturbed on binding PLP to give rise to 
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the changes in the circular dichroism (Yang et , 1975). On 
the other hand, since binding of PLP to one subunit of the apo-
enzyme dimer causes a conformational change in the other subunit 
(Schlegel and Christen, 1974; Arrio-Dupont and Cournil, 1975), the 
perturbed residue may be tryptophan-295 which is located at the 
subunit interface, close to the molecular diad. 
The observed failure of apoenzyme modified by tetranitromethane 
to recombine with PLP (Turano et aj_., 1971) may have been due to 
nitration of tyrosine-225, which binds the phenolic oxygen of the 
coenzyme, or of tyrosine-70, which forms a hydrogen bond to the 
phosphate group. 
The identity and location of the reactive histidine residue 
are not clear from the electron density map. Histidine residues 
143, 189, and 193 are located closer to the active site than the 
others, but are deeply buried within the protein and so would not 
be accessible to photosensitizing dyes or chemical reagents. 
Histidines 317, 352, and 378 are all located on the surface of the 
protein, but are far from the active site. Histidine-68 is both 
inaccessible and too far from the active site. Morino et aj_. (1979) 
have concluded that the critical histidine is residue 405, but this 
residue is located in the a-helix which forms the C-terminal segment 
and is far from the active site. What is clear is that there is no 
histidine located in the active site to remove the a-proton of the 
amino acid substrate, contrary to some suggestions (Peterson and 
Martinez-Carrion, 1970). 
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Modification by Coenzyme Analogs 
In earlier work by Yang et (1974) it was proposed that 
pyridoxal sulfate reacts at the active site of the apoenzyme of 
aspartate aminotransferase since the enzyme is inactivated in the 
course of the reaction and can no longer bind its natural coenzyme, 
pyridoxal phosphate. The absorption spectrum taken within a few 
minutes of mixing the coenzyme analog with the apoenzyme suggests that 
a Schiff base is formed initially, but later spectra suggest a more 
complicated reaction follows. The purpose of this research is to 
investigate this reaction further to identify the amino acid residue(s) 
of the protein that are involved in the reaction, and to gain information 
about the structure of the reaction product. 
Since PLS appears to react at the active site of apoAAT, it was 
presumed that PLS reacted first with lysine-258 to form a Schiff base. 
Cysteine-390 was thought to be the residue most likely to react with 
the Schiff base because it was known to be located near the active 
site and because the reaction of PLS with cysteine in solution 
showed spectral characteristics remarkably similar to those of the 
enzymatic reaction. If cysteine-390 were involved in the reaction, 
then modification of this residue would be expected to interfere with 
the reaction. In the clearest case, PLS would be able to form a 
Schiff base with the modified apoenzyme but not be able to react 
further. 
ApoAAT 70% modified at cysteine-390 with cyanide reacted with 
PLS to form a species absorbing at 402 nm (24.9 kK) at pH 8.3. The 
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absorbance band was narrow with pronounced vibronic fine structure 
and closely resembled the absorbance of the product of the reaction 
with the unmodified apoenzyme. The 402-nm peak formed faster and 
reached a higher absorbance in the reaction with the modified apoenzyme 
than in the reaction with the unmodified apoenzyme. Yang et al. 
reported that the 402-nm peak reached a maximum molar absorptivity 
of 1.0 X 10"^ M"^cm~^ in about 2 h. With the modified apoenzyme 
(Figure 5), this peak reached a maximum molar absorptivity of 
1.4 x 10^ M'lcm'l in only 1 h, and the initial complex spectrum was 
not recorded. However, another sample of apoAAT, which was only 
50% modified at cysteine-390, reacted more slowly with PLS than 
the sample in Figure 5, and the spectral changes more closely resembled 
those described for the reaction with the native apoenzyme. In either 
case, it is apparent that PLS and apoAAT that has been modified at 
cysteine-390 react in a way not fundamentally different from the 
reaction of the unmodified apoenzyme. It is unlikely that the 
reaction proceeded after the elimination of the blocking group 
to regenerate the sulfhydryl because the reactions that modified 
the sulfhydryl result in its oxidation. Cyanide could not be 
eliminated without leaving the sulfur atom severely electron-dificient. 
The thiocyanide itself is not a nucleophile and so could not mimic 
the sulfhydryl in the reaction. Furthermore, the 2.7 X electron 
density map of native AAT indicates that cysteine-390 is located 
10 R away from the active site, too far to participate in the reaction. 
Thus, cysteine-390 is not the unknown nucleophile that reacts with 
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the PLS-lysine Schiff base. 
Isolation of modified peptides 
The specificity of bond cleavage by trypsin or chymotrypsin 
make these enzymes the first choices for hydrolysis of a modified 
protein in locating sites of modification. Trypsin would be expected 
to cleave a peptide of twenty-five residues from the active site of 
AAT, while chymotrypsin would most likely leave a tetrapeptide. 
Since a tetrapeptide would be easily characterized and identified within 
the amino acid sequence, chymotrypsin was preferred for this study. 
Unfortunately the PLS chromophobe proved to be unstable under the 
conditions for digestion by either chymotrypsin or trypsin. During 
the digestion the visible absorption spectrum of the PLS chromophore 
was lost. The chromophore presumably converted to a form whose 
absorption is obscured by the 280-nm band of the aromatic amino acids, 
as it does when the protein is denatured at high pH. Attempts to 
isolate a peptide containing this new form of PLS were unsuccessful. 
Because its absorption spectrum was not characterized, there was no 
means of quantifying the desired material or even of locating it 
definitely. Yang e;t (1974) speculated that when the 400 nm 
band disappeared after the modified enzyme was denatured in 6 M 
guanidine hydrochloride at high pH, a reaction occurred that led to 
a shift of the absorption band of the chromophore into that of the 
aromatic amino acids of the protein. Such an absorption spectrum, 
even if it were well-characterized, would be of little use in following 
the chromophore through an isolation procedure because of the inter­
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ference of the absorptions of tryptophan and tyrosine. The presence 
of pyridine and collidine in the buffers used to elute peptides 
from the Dowex-1 column made the ultraviolet region of the ab­
sorption spectrum completely inaccessible. 
There was a species with a blue-white fluorescence present in 
the chymotrypsin digest of PLS-modified apoAAT. I attempted to 
isolate this species, thinking that it may be a peptide modified 
with the altered PLS chromophore. However, peptide maps of fractions 
from the Dowex-1 column that contained the blue-white fluorescence 
showed that the fluorescence was not associated with any ninhydrin-
positive material, and so this course was abandoned. 
As reported by Yang et (1974), the product of the reaction 
of PLS with apoAAT is stable at low pH for many days, even after 
the protein is denatured in 6 M guanidine hydrochloride. Therefore 
pepsin, which is active at low pH, was chosen to digest the modified 
protein, although it lacks the specificity of trypsin or chymotrypsin. 
The PLS chromophore survived digestion by pepsin at pH 2.5 for 
5 h with almost no decrease in the intensity of its absorbance. 
The absorption peak shifted slightly during the digestion, from 386 
to 382 nm (25.9 to 26.2 kK), but this was probably due to the dis­
ruption of the protein structure and loss of its interactions with 
the chromophore rather than any destruction of the chromophore. The 
environment of the coenzyme in the active site of the enzyme is 
thought to be rather hydrophobic. The structure of the coenzyme 
pocket is destroyed as the protein is digested, leaving the PLS 
100 
chromophore in an aqueous environment. After digestion, the chromo-
phore could be converted to its form absorbing at 400 nm by adjusting 
the pH to 8. This indicates that the PLS chromophore is unaltered 
by treatment by pepsin. 
Two peptides that contained the PLS chromophore were isolated 
from the pepsin digest using gel chromatography and thin layer 
electrophoresis. Gel chromatography on Sephadex G-25 or G-15 
separated the modified peptides from most of the other peptides in 
good yields. The losses could be explained by a very low absorbance 
at 382 nm in all the fractions and by the tailing fractions which 
were discarded. Electrophoresis at pH 1.9. separated the modified 
peptides into at least four bands. Peptide 4 was occasionally 
obtained in an almost pure state from this step. A second electro­
phoresis at pH 4.7 was used to further purify peptide 2 and peptide 
4. The fluorescent bands on the pH 4.7 electrophoresis plates were 
often very broad. Because of this, the contaminating peptides were 
often not well-separated from the desired peptide, and the yields 
were poor. The losses on electrophoresis were in part due to the 
spreading of the bands, since only the center of a band was taken 
to avoid including contaminating peptides. In order to keep the 
sample application line narrow, the samples were applied in very 
small volumes. This led to significant losses in the transfer, 
usually amounting to about 10% of the sample. 
The alternative method for the isolation of the modified 
peptides, using gel chromatography, thin layer chromatography. 
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and thin layer electrophoresis, was used for a large scale prepara­
tion of peptides. Peptides 2 and 4 that were isolated in this manner 
were the same as those isolated by the original method, but were 
more pure. In addition a quantity of peptide 3 was also isolated 
and analyzed. 
Characterization of the peptides 
Peptide 4 from band 4 of the thin layer electrophoresis plate 
at pH 1.9 is Ser-Lys*-Asn. Amino acid analysis of peptide 4 after 
acid hydrolysis showed aspartate, serine and lysine in amounts 
approximately equal to the amount of PLS chromophore. Electrophore­
sis or thin layer chromatography of samples of peptide 4 that had 
been digested with aminopeptidase M showed that asparagine, not 
aspartic acid, was present in the peptide. The amino-terminal 
residue was serine. The peptide Ser-Lys*-Asn, where lys* is a 
lysine residue modified by PLS, corresponds to residues 257 through 
259 in the protein and includes the active site lysine-258. 
Peptide 2 was purified from band 2 of the pH 1.9 thin layer 
electrophoresis plate. The amino acid analysis of this peptide 
gave aspartic acid or asparagine, serine, glycine, leucine, phenyl­
alanine, and lysine in amounts approximately equal to the amount of 
PLS chromophore. The amino terminus is serine. This peptide is 
therefore Ser-Lys*-Asn-Phe-Gly-Leu, residues 257 through 252 of the 
protein. 
Peptide 3 is made up of aspartate or asparagine, serine, phenyl­
alanine, and lysine. Phenylalanine is the amino terminal residue. 
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The peptide is therefore Rhe-Ser-Lys*-Asn, residues 256 through 259 
of the protein. 
Band 1 from the electrophoresis at pH 1.9 most likely also 
contains a peptide or peptides that span lysine-258 modified by PLS. 
However this band contained only a small amount of the chromophore, 
so the peptides were never analyzed. 
All the peptides containing the PLS chromophore that were analyzed 
include the active site lysine. This provides strong evidence that 
PLS binds to apoAAT in the same site as PLP. 
The heterogeneity in the modified peptides is probably due to 
the lack of specificity in digestion by pepsin. However, prolonged 
digestion by pepsin could not convert all of the product to the 
smallest peptide, peptide 4. 
Significant amounts of histidine were frequently indicated in 
the amino acid analyses of the PLS peptides, especially in those 
samples where the lysine content was less than expected. However, a 
sample of peptide 3 which showed histidine in the amino acid analysis, 
was tested with a reagent for histidine and showed none. The 
"histidine" in the amino acid analysis was possibly a modified lysine. 
A modified lysine would be retarded on the analyzer column if it were 
made more hydrophobic or if its pK were raised. Reaction of PLS 
with the G-amino group of lysine could do either of these. 
In the amino terminal analysis of each of the PLS peptides there 
was one fluorescent product which could not be identified as a 
dansylamino acid. I believe that this product may be due to the 
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reaction of dansyl chloride with the PLS product, possibly at the 
phenolic oxygen of the pyridoxyl moiety. Dansyl chloride reacts 
with the phenolic oxygen of tyrosine, and the 0-dansyl derivative 
has an orange fluorescence similar to that of the mysterious product 
from the PLS peptide. Furthermore, its location after thin layer 
chromatography on polyamide sheets is in the area of the dansyl 
derivatives of the large hydrophobic amino acids. 
Interaction of the coenzyme analogs and apoenzyme 
Yang et aj_. (1974) suggested that pyridoxal sulfate may act as 
a crosslinking reagent for two residues at the active site of 
aspartate aminotransferase, probably lysine-258 and some unknown 
group held by the enzyme in close proximity to the 4'-carbon of the 
coenzyme analog as it is held in a Schiff base linkage. I originally 
hypothesized that this unknown group was the sulfhydryl of cysteine-390, 
the syncatalytically modifiable sulfhydryl. This residue seemed to 
be the most likely candidate because it was already known to be 
located near the active site and because the model reaction of 
cysteine with PLS showed similar spectral properties to the enzymatic 
reaction. However, this hypothesis was disproved when PLS reacted 
with apoenzyme that had been blocked at cysteine-390 with cyanide, 
as shown by the spectral changes recorded in Figure 5. Further­
more, the modified peptides that were isolated were all single 
peptides containing lysine-258 but not cysteine-390, and the 
crystallographic structure of the native enzyme shows that cysteine-
390 is not in the active site. Therefore, the unknown nucleophile 
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in the PLS reaction cannot be the sulfhydryl of cysteine-390. 
Now that the peptides containing the PLS product have been 
identified, it is possible to speculate on the identity of the 
nucleophile and the nature of the product. If pyridoxal sulfate 
reacts to form a crosslink between lysine-258 and the side chain of 
another amino acid, and the cross-link is stable, then the nucleo­
phile must be part of the same peptide since all three modified 
peptides were single peptides. The side chain of serine-257 
or asparagine-259 are the only possibilities, since these two are 
the only other residues common to all three peptides. Of the two, 
the hydroxyl of the serine is more likely to participate in the 
reaction because it is a stronger nucleophile than the amide of 
asparagine. Serine reacts with PLS in solution at pH 9 to give 
a product with a narrow absorption band at 403 nm (24.8 kK) which 
has pronounced fine structure similar to the product of PLS with 
the apoenzyme (Yang et a]_., 1974). In the electron density map at 
2.7 % resolution of native aspartate aminotransferase it appears 
that residues 256 to 260 (phe-ser-lys-asn-phe) form a single turn 
of a helix, and that the side chains of all the residues involved 
are oriented downward, roughly antiparallel to the helical axis. 
Thus, the hydroxyl of serine-257 is located only a few R from the 
Schiff base linkage between lysine-258 and pyridoxal phosphate. 
Very little reorientation either of the side chain of serine-257 
or of pyridoxal sulfate within the coenzyme pocket of AAT would be 
necessary to allow the serine hydroxyl to react with the Schiff base. 
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This is the most attractive possibility for the identity of the unknown 
nucleophile. 
Assuming that the unknown nucleophile is the hydroxyl of serine-
257, it becomes possible to explain the properties of the chromophoric 
product of pyridoxal sulfate and apoAAT as shown in figure 28. 
Structure I represents peptide 4 at low pH, where it absorbs at 
382 nm. This structure is fully protonated and unreactive. When 
the pH is raised to 8, the most acidic group, the phenolic oxygen, 
becomes deprotonated and forms a hydrogen bond with the Schiff base 
nitrogen, as in structure II. This may be the structure of the 
chromophore absorbing at 400 nm. In basic solution this structure 
could be hydrolyzed to a free serine residue and an amide of lysine-
258 and deoxypyridoxic acid (structure III). This is seen as the 
irreversible loss of the absorbance at 400 nm on incubation at pH 
8 or above. The 400-nm structure could be stable in the intact 
protein because of the close positioning of serine to the coenzyme 
or because the protein structure makes structure II inaccessible 
to hydroxide. The amide of structure III should be reasonably 
stable so that the chromophore remains attached to the peptide. 
Under rigorous conditions, such as those used to hydrolyze the 
peptides for amino acid analysis, the amide would be expected to 
give free lysine and 5'-deoxypyridoxic acid, structure IV, A non­
specific protease, such as aminopeptidase M, may also cleave the 
amide so that very little or no modified lysine is detected in 
the digest on electrophoresis or thin-layer chromatography. 
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H^N-ser-lys-asn-COO 
HO 
Q % 
HgN-ser-Tys-asn-COO 
HO 
Q 
III IV 
Figure 28 Possible reactions of the proposed pyridoxal chromophore 
involving lysine-258 and serine-257 of peptide 4. 
(See text for discussion.) 
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The major problem with this scheme is that it does not predict 
a structure for the putative modified lysine which runs on the amino 
acid analyzer column as histidine. Any of the structures in figure 
26 would be expected to hydrolyze to lysine and deoxypyridoxic acid. 
Another difficulty is that Yang ^ a]_. (1974) found that the transition 
from the 386-nm chromophore to its form absorbing at 402 nm in 
the intact protein was not governed b'y a single pKa. The proposed 
analogous transition from structure I to structure II is a simple 
deprotonation. 
Alternatively, the reaction may involve an amino acid side 
chain that is broken down in the course of the reaction leaving 
a fragment attached to the coenzyme. In this case an amino acid 
located some distance away from lysine-258 in the amino acid sequence 
would be involved in the reaction, but the formation of a crosslink 
would not be apparent from the isolated peptides. The guandino 
group of arginine and the imidazole of histidine are two possibilities 
for such a nucleophile. Both amino acids have been suggested in the 
active site from chemical modification studies, and both could be 
unstable if modified. 
The X-ray crystallographic structure of the native enzyme shows 
no histidine residues near the Schiff base linkage between lysine 
and PLP, so this possibility must be discarded. On the other hand, 
there are several arginine residues near the coenzyme. Arginine-386 
and arginine-292 apparently bind the two carboxyls of substrates, 
while arginine-266 interacts with the coenzyme phosphate. In the 
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2.7 8 electron density map it appears that arginine-386 could attack 
the PLS-lysine Schiff base if the coenzyme were a little crooked in 
the PLP site. This could result in the guanidino group breaking to 
leave a fragment attached to the PLS-lysine chromophore. Hydrolysis 
of this structure at pH 8 would be similar to the reaction in Figure 
28, and would produce the same amide product as structure III in that 
scheme. 
Another possibility is that the reaction simply involves water 
or hydroxide as the unknown nucleophile. The Schiff base of valine 
and PLS in solution at very high pH exhibits changes in its absorption 
spectrum that are similar to those seen in the reactions of PLS with 
apoAAT or g-substituted amines (A.E. Cahill, Department of Biochemistry, 
Iowa State University, unpublished results). The apoenzyme may be 
able to catalyze a similar reaction at a lower pH. However, such a 
structure would be expected to tautomerize rapidly to the amide, and 
from there it is not possible to write plausible chemical reactions to 
explain the complex conversions of the chromophore. 
Whatever the nucleophile that reacts with the enzyme-PLS Schiff 
base, the apoenzyme must play an active role in its addition. In 
solution PLS reacts with awide variety of amines and amino acids with 
nucleophilic substituents to produce spectral changes similar to those 
of the enzymatic reaction, but Schiff bases of PLS with valine or 
butylamine do not undergo further reactions at moderate pH. This 
indicates that the nucleophile must be held by the protein in close 
proximity to the Schiff base, and that the protein facilitates its 
addition to the Schiff base. 
109 
Miura and Metzler (1976) suggested that, because the reactions 
of apoAAT with pyridoxal sulfate and with the 5'-trans-carboxy-
ethenyl analog of PLP were so similar, the unknown nucleophile 
was probably the same in both cases. The similarities in the peptides 
from the pepsin digestion of apoenzyme modified by the two coenzymes 
makes this all the more likely. 
Aspartate aminotransferase is the only enzyme that is known 
to react with PLS in this way. However none of the other enzymes 
that have been tested are aminotransferases. This raises the question 
of whether the reaction is a quirk of this enzyme, or whether it is 
related to a step in the catalytic sequence that is unique to trans­
amination. If the latter is the case, one would expect to see a 
similar reaction of PLS with other aminotransferases but not with 
vitamin Bg-dependent enzymes that catalyze other types of reactions. 
Dr. Retsu Miura is investigating the reactions of PLS and the 
carboxyethenyl analog with pig heart mitochondrial aspartate amino­
transferase (personal communication). The results of his experiments 
ought to indicate whether the reaction is general among aminotrans­
ferases. Furthermore, the mitochondrial enzyme has an alanine residue 
rather than serine preceding the active site lysine (Morino and 
Watanabe, 1969; Kagamiyama e^ , 1977; Barra et al_., 1977). 
Therefore if PLS reacts with mitochondrial AAT as it does with the 
cytoplasmic isozyme, the hydroxyl of serine-257 can be fully ruled 
out as the unknown nucleophile. 
Pyridoxal phosphate modifies either the mitochondrial or cytosolic 
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isozymes of mal ate dehydrogenase from pig heart in a reaction that 
bears some resemblance to the reaction of PLS with apoAAT (Wimmer 
, 1975; Bleile et , 1976). In the case of PLP and the malate 
dehydrogenases the reaction is clearly biphasic. The first phase, 
which is reversible, is the formation of a Schiff base between PLP and 
a lysine residue in the enzyme active site. The second phase is irre­
versible and apparently involves the attack of a second nucleophilic 
group of the protein on the PLP-lysine Schiff base to form an X-azoli-
dine similar to an intermediate in the proposed reaction of PLS and 
apoAAT. The Schiff base of PLP and mitochondrial malate dehydrogenase 
was reduced with sodium borohydride and digested with trypsin, and a 
labeled hexapeptide was isolated and sequenced (Wimmer and Harrison, 
1975). The X-azolidine product was stable when denatured in 6 M urea 
and digested by trypsin, in contrast to the PLS-AAT product. A peptide 
has been isolated whose amino acid content was consistent with the 
hexapeptide of the reduced Schiff base with eight additional residues 
(Gowan and Harrison, 1979). However, the fluorophore was destroyed in 
the final purification step, electrophoresis at pH 3.7. Gowan con­
cluded that the unknown nucleophile was in a peptide contiguous with 
the hexapeptide, and that it was most likely an arginine residue (L.K. 
Gowan, Department of Biochemistry, Medical University of South Carolina, 
personnal communication). 
The reaction of PLP with malate dehydrogenase and the reaction 
of PLS with apoAAT appear to be similar in some respects. Both 
coenzymes react initially to form Schiff bases with specific lysine 
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residues of the proteins. In both cases an unknown nucleophile then 
attacks the Schiff base to form an X-azolidine structure. It is 
unknown whether phosphate is eliminated from the PLP-dehydrogenase 
X-azolidine, so this may not proceed through reactions analogous 
to the final steps of the PLS-AAT reaction sequence. Both reactions 
are irreversible in the absence of reduction, which is rare in 
reactions of pyridoxal compounds. However, while the PLS peptides 
from AAT are single peptides, the PLP peptide from mal ate dehydrogen­
ase seems to be crosslinked although this peptide has not been 
characterized except by amino acid analysis. 
It is interesting to note that the amino acid analysis of the 
X-azolidine peptide that Gowan isolated showed 0.6 equivalent of 
histidine. She stated (personal communication) that she originally 
believed this to be a contaminant, but finally concluded that there 
was really a histidine. In the light of the false indication of 
histidine in the amino acid analysis of the PLS peptides from apoAAT, 
this is intriguing. The "histidine" may be due instead to a PLP-
modified lysine similar to the "histidine" of the PLS peptides. 
Of course, if PLP retains its phosphate group in the reaction with 
the malate dehydrogenase, it would hardly behave like the PLS product 
on the analyzer column. 
The nature of the product of the reaction of pyridoxal sulfate 
with apoAAT needs further investigation. Its structure may become 
clear when the X-ray structure of the PLS-enzyme complex has been 
determined. The low-pH form of the complex has been crystallized 
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under the same conditions used to crystallize native AAT. The 
crystals have the same brilliant blue-white fluorescence under 
ultraviolet light as the enzyme-bound product in solution and the 
modified peptides (Figure 29). 
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Figure 29 A. Crystals of aspartate aminotransferase modified 
by pyridoxal sulfate. 
Figure 29 6. The same crystals illuminated by UV light. 
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CONCLUSIONS 
Aspartate aminotransferase has been crystallized by the vapor 
diffusion technique of McPherson (1976). In order to obtain heavy 
atom derivative crystals of the enzyme, the native enzyme and 
enzyme blocked at one or both of its surface sulfhydryls with small 
uncharged substituents was crystallized in the presence of one or 
two equivalents per monomer of methylmercuric chloride, £-chloro-
mercuribenzoate or mercuric acetate. Although crystals formed with 
almost every combination of blocking group and mercury reagent, only 
one crystal was large enough for crystallography. A crystal of 
AAT blocked at both surface sulfhydryls with N-ethylmaleimide and 
crystallized with one equivalent of methyl mercury showed one major 
and one minor mercury site in each monomer. The major site was 
cysteine-191 and the minor site was cysteine-82. These same two 
sites were occupied by methylmercury in a crystal of unmodified 
AAT. Mercuribenzoate binds to cysteine-82 and cysteine-45. 
Crystals of AAT containing two equivalents of methylmercury or 
mercuribenzoate have provided the two heavy atom derivatives used 
in calculating an electron density map at 2.7 K resolution. Most 
of the polypeptide chain has been traced in this map. A crystal of 
apoenzyme was used to locate the binding site of the pyridoxal 
phosphate cofactor. 
Pyridoxal sulfate reacts at the active site of apoAAT to 
modify lysine-258. Three peptic peptides from the enzyme modified 
by pyridoxal sulfate have been isolated and characterized by amino 
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acid analysis and N-terminal analysis. All include the active 
sequence ser-lys-asn-259. The identity of the second nucleophile 
involved in the reaction of PLS with apoAAT is still unknown. The 
isolated peptides were all single sequences with no apparent crosslink. 
From the X-ray structure of native AAT, it appears that the 
hydroxy1 of serine-257 is in a position to participate as the 
second nucleophile in the reaction. Because it is close to the PLP-
lysine Schiff base, it is most likely to react with the PLS-lysine 
Schiff base. If some distortion occurs in the active site of AAT 
when PLS binds, the guanidino group of arginine-386 could also 
be in a position to act as the unknown nucleophile. In this case, 
one must hypothesize that only a fragment of the arginine becomes 
incorporated into the PLS product since no arginine is indicated 
in the amino acid analyses of the isolated peptides. Hydroxide 
from the solvent may also be the nucleophile, but this possibility 
is less attractive than the others. 
The 5'-trans-carboxyethenyl analog of PLP probably modifies 
the same active site peptides as PLS. The peptides modified with 
this analog behave similarly to the PLS peptides in the isolation 
procedures. However, peptides containing the carboxyethenyl analog 
were not isolated in sufficient yield to be characterized. 
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